TSS:Rfhg 80761.1

Basic information about the TSS

---

TSS ID: rfhg_80761.1 TSS ID(Version3): hg_72773.1 hg_72774.1 Species: human Chr: chr6		Start: 31652626 End: 31652692 Strand: -
Source datasets
Protocol
TSS cluster detected*

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3831452,EH38E2459342)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000437771.5:0 ENST00000451898.5:0 ENST00000424480.5:0 AK302695:0 M33519:0 AK304879:0 GeneID: 7917 HGNC/MGI_ID: HGNC:13919 UniProt_ID: A0A1B0GX79 F6VEM6 X6REW1 Nearer transcript ids and distances:

Gene_name: BAG6 Gene_symbol: BAG6 Gene_synonyms: D6S52E G3 Scythe Gene_source: HGNC:13919

TATA-Box annotation

---

Distance to TSS:	2
Nearest PromoterID:	NM_080703
Entrez ID:	7917
Nearest Unigene:	Hs.440900
Nearest Refseq:	NM_004639
Nearest Ensembl:	ENSG00000204463
Gene Name:	BAG6
Gene Alias:	BAG-6|BAT3|D6S52E|G3
Gene Type:	protein-coding
CpG%:	0.151515
GC%:	0.656716
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@BAG6 p2@BAG6 p3@BAG6 p4@BAG6 p5@BAG6 p6@BAG6 p7@BAG6 p8@BAG6 p9@BAG6 p10@BAG6
Sample		p1@BAG6	p2@BAG6	p3@BAG6	p4@BAG6	p5@BAG6	p6@BAG6	p7@BAG6	p8@BAG6	p9@BAG6	p10@BAG6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	139.09	0.39	10.13	0.00	1.56	0.78	0.58	0.39	1.36	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	157.81	0.81	9.10	0.40	1.21	1.21	2.02	0.20	1.82	2.02
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	146.80	0.39	9.84	0.58	0.96	0.19	1.93	0.58	1.93	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	139.92	0.62	11.64	0.21	1.66	0.00	1.25	0.21	1.66	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	156.35	1.12	6.97	0.90	0.90	0.45	0.67	0.45	2.47	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	143.03	1.16	6.98	0.78	1.74	0.00	2.13	0.39	1.16	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	162.76	0.87	16.34	0.65	1.31	0.00	3.70	0.22	2.61	2.83
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	158.65	0.00	11.38	0.24	1.70	0.24	2.18	0.24	2.42	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	160.93	0.64	9.62	0.00	0.64	0.21	1.92	0.00	1.50	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	131.00	0.00	7.54	0.00	1.16	0.00	2.32	0.58	2.90	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	118.04	0.40	10.91	0.40	3.23	0.81	2.43	0.00	2.83	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	125.22	0.81	10.16	0.41	2.85	0.41	2.44	2.03	1.63	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	32.88	4.35	1.61	3.87	1.61	2.90	1.61	1.93	0.81	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	29.47	4.06	1.80	4.81	1.80	2.86	1.80	1.80	1.35	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	22.39	3.51	1.54	3.51	0.66	2.63	1.54	1.54	1.10	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	24.90	3.77	1.51	3.27	1.51	2.77	1.01	2.01	1.26	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	26.43	2.84	1.97	4.15	1.75	2.40	1.09	0.87	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	22.36	1.69	1.69	4.64	0.84	2.95	0.00	2.11	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	25.59	0.53	0.53	5.86	3.73	2.67	1.07	2.13	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.82	4.06	2.41	4.36	1.20	2.56	0.90	0.75	1.05	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	28.33	4.81	1.34	3.07	2.54	2.54	1.07	0.67	2.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	24.34	5.52	1.73	4.49	1.90	2.42	0.35	1.04	0.69	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.95	2.84	2.07	3.62	1.55	3.10	1.55	1.68	0.52	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	24.75	3.15	2.43	3.40	0.97	2.43	1.21	1.94	0.73	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	25.03	2.06	1.81	5.93	1.81	1.03	1.03	0.77	1.81	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	29.75	1.90	1.27	3.80	1.27	1.90	0.32	0.32	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	15.38	1.65	2.75	4.40	1.65	2.75	1.10	0.55	0.55	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	32.30	4.95	1.89	3.30	1.41	3.30	0.94	2.36	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	20.84	3.07	0.81	2.10	1.29	2.58	0.32	0.97	0.97	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	24.61	4.52	0.90	2.90	1.99	1.81	0.54	0.90	1.27	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	21.14	1.67	0.84	1.88	1.05	1.67	1.26	2.72	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	20.91	2.74	0.78	1.37	0.39	2.54	0.59	0.78	0.59	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	27.86	2.74	2.53	3.17	0.84	1.90	0.42	1.69	2.74	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	24.74	2.31	0.99	5.11	1.81	3.46	0.33	1.81	0.99	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	29.92	2.99	1.50	3.37	1.31	2.99	0.37	1.12	1.12	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	26.44	3.45	1.72	1.53	1.34	1.53	0.19	1.15	0.77	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	24.73	2.86	1.43	2.04	1.02	1.64	0.41	0.82	1.84	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	26.80	1.81	1.01	2.01	1.01	3.02	0.20	1.61	0.81	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	27.28	3.24	1.89	2.97	1.35	3.24	0.81	1.08	0.54	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	25.21	2.16	0.96	3.12	0.48	1.92	0.48	1.20	1.68	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	20.70	3.29	0.94	2.12	1.18	2.35	1.88	0.94	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	24.16	2.64	1.02	2.34	2.34	2.93	1.02	2.05	1.02	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	23.41	2.53	1.69	2.11	1.69	2.32	0.63	1.05	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	24.13	2.97	1.05	2.27	1.40	1.92	0.87	1.05	0.87	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	24.29	4.62	1.00	2.41	2.61	1.61	0.60	1.41	0.80	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	27.68	2.33	1.40	0.70	0.47	3.26	0.47	0.93	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	24.95	2.64	1.92	2.64	1.20	3.12	0.72	1.92	1.44	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	22.35	2.68	2.09	0.60	1.49	3.58	0.89	0.89	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	28.72	2.39	1.20	1.68	1.91	3.11	0.48	0.24	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	25.48	2.43	0.40	2.22	1.62	2.63	0.61	0.61	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	32.38	1.64	4.30	1.64	1.64	2.87	0.82	0.61	1.23	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	33.36	2.00	1.33	3.78	1.11	3.11	2.45	1.33	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	13.99	0.00	0.00	0.00	0.00	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	30.52	0.35	2.84	1.77	0.00	3.55	0.35	1.06	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	32.48	0.33	1.66	2.65	0.99	3.31	0.33	0.99	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	31.88	5.87	0.00	2.52	0.84	5.87	5.87	3.36	5.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	20.21	2.76	1.38	2.76	0.46	3.67	0.46	2.30	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	36.62	0.32	2.59	1.30	0.97	1.30	1.30	0.97	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	33.08	0.64	2.25	1.93	0.64	2.89	1.28	0.64	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	29.55	2.83	3.14	2.20	2.51	2.20	1.26	1.57	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	43.01	1.41	4.94	2.82	0.00	2.12	0.71	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	39.26	0.56	1.12	2.24	1.12	1.68	1.12	0.00	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	20.70	7.17	1.59	1.59	4.78	3.18	0.80	2.39	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	21.07	2.04	2.38	2.72	0.68	3.06	0.00	1.70	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	29.57	0.00	0.65	1.62	1.30	4.22	1.30	0.65	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	32.30	0.71	4.26	1.06	2.13	1.06	0.71	1.77	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	16.16	0.00	0.00	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	23.69	0.00	0.00	0.00	7.90	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	50.21	0.00	1.95	1.46	0.98	0.98	0.49	0.98	0.98	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	41.16	0.99	1.98	1.49	0.50	2.48	1.49	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	32.84	1.88	3.75	2.35	0.47	1.41	1.41	0.94	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	25.50	0.99	2.32	0.00	1.99	4.64	0.33	0.33	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	39.60	0.93	0.62	0.93	0.62	3.09	0.31	0.62	0.62	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	39.14	1.22	2.14	1.53	0.61	0.61	0.92	0.31	0.00	1.22
Adipocyte - breast, donor1	11376-118A8	41.50	1.27	1.74	1.74	0.48	0.79	0.79	0.16	0.95	0.48
Adipocyte - breast, donor2	11327-117E4	40.91	0.96	2.73	2.57	0.96	0.64	0.96	1.60	1.12	0.32
Adipocyte - omental, donor1	11473-119C6	36.51	1.53	2.04	3.18	1.02	0.89	1.27	0.76	1.02	0.00
Adipocyte - omental, donor2	11474-119C7	33.64	2.99	0.75	0.75	0.75	2.24	0.00	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	26.46	1.67	1.34	3.01	0.33	1.00	1.00	1.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	24.88	1.28	1.91	0.64	0.00	1.28	0.64	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	24.19	0.00	0.00	1.10	0.00	1.10	1.10	0.00	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	44.71	0.90	2.71	0.90	0.90	0.90	0.45	0.90	1.35	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	41.36	1.22	1.91	2.78	1.22	2.09	1.04	1.91	2.26	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	33.83	3.52	1.56	3.32	2.15	0.59	1.17	1.96	0.20	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	31.14	1.54	2.57	3.86	1.80	1.54	1.03	1.03	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	39.86	2.51	1.95	3.35	1.67	1.12	1.67	0.56	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	41.15	1.76	0.59	2.94	0.59	1.18	0.59	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	47.46	4.10	1.45	4.99	1.85	1.37	2.09	2.09	0.32	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	35.18	2.90	1.29	3.87	0.00	1.29	1.29	2.58	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	25.59	2.67	2.13	4.27	2.13	0.53	2.13	2.13	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	36.17	0.00	1.67	3.90	0.56	0.00	0.56	2.78	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	52.82	0.83	2.08	2.91	2.08	0.42	0.83	1.25	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	34.41	2.76	1.76	6.28	1.51	0.25	2.01	1.76	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	46.14	0.33	2.29	3.60	1.31	1.31	3.27	2.62	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	34.10	2.74	1.52	3.96	1.22	0.61	2.13	1.22	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	62.76	2.65	2.43	2.21	0.44	2.87	0.88	2.65	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	112.95	5.38	3.59	0.72	0.36	1.43	1.79	1.79	0.36	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	65.89	2.40	1.20	4.79	0.00	2.40	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	64.23	3.60	2.34	1.98	0.72	1.80	0.72	0.72	0.36	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	66.94	3.35	3.35	5.02	1.67	5.02	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	60.20	2.88	1.85	3.70	1.03	1.64	0.82	1.23	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	36.27	3.66	2.06	6.87	2.40	5.72	2.52	1.37	1.37	0.46
Anulus Pulposus Cell, donor2	11463-119B5	26.45	6.12	2.20	4.90	0.24	3.18	0.98	1.22	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	36.39	2.70	1.35	3.59	0.90	0.45	1.35	1.35	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	36.03	3.04	4.78	1.74	1.30	2.17	0.43	2.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	0.00	0.00	4.28	0.00	2.14	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	31.09	2.99	0.90	3.89	1.49	2.39	0.90	1.49	1.20	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	30.35	5.06	2.53	1.26	0.00	1.26	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	22.44	2.64	0.66	3.30	0.00	0.66	0.66	1.32	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	34.11	3.90	1.62	3.25	0.32	1.30	0.32	0.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	36.41	2.91	1.94	2.91	2.91	1.94	0.00	1.46	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	27.32	2.97	1.78	4.75	1.19	0.00	0.00	1.19	1.78	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	29.00	1.88	1.51	4.14	0.75	0.75	1.51	1.51	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	31.20	3.63	0.73	2.18	2.90	0.73	0.00	1.45	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	15.05	3.76	1.25	1.25	1.25	1.25	2.51	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	27.02	1.65	1.65	3.62	1.65	1.15	0.82	0.82	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	30.03	2.73	0.00	5.46	0.00	1.36	1.36	0.00	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	22.17	0.90	1.21	1.96	0.60	1.51	0.30	1.21	0.45	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	38.04	1.61	0.54	1.07	1.07	1.07	0.00	1.07	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	25.13	1.89	0.76	2.65	1.13	2.08	0.57	1.70	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	31.27	1.34	2.94	5.88	2.41	2.41	1.87	1.07	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	28.29	1.95	1.95	1.95	0.00	1.95	1.95	1.95	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	29.85	2.49	1.16	2.99	1.99	3.32	1.00	1.16	0.83	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	18.01	0.00	2.40	4.80	1.20	1.20	0.00	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	3.54	7.08	3.54	0.00	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	29.33	2.92	1.20	3.26	1.20	0.69	1.20	1.03	1.03	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00	4.19	4.19	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	37.38	3.88	1.46	3.40	0.49	2.91	0.49	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	26.56	5.69	1.52	3.79	1.90	4.93	0.76	0.76	0.38	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	32.71	1.21	2.42	2.42	1.21	0.00	2.42	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	22.23	1.14	2.85	3.42	1.14	3.99	0.57	1.14	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	25.01	3.21	1.50	3.21	1.92	2.35	0.86	0.64	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.00	0.52	2.32	2.58	0.77	1.29	0.77	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	39.41	2.82	0.47	5.16	0.47	1.88	0.00	2.82	1.41	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.79	1.61	1.93	2.89	0.96	3.54	0.64	1.93	1.29	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.82	0.71	2.14	4.28	0.71	0.00	0.00	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	32.17	2.34	1.75	0.58	0.00	2.34	1.17	0.00	1.17	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	26.49	2.71	1.51	2.11	0.90	1.81	1.20	1.81	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	22.57	2.38	1.19	1.19	2.38	2.38	0.00	2.38	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	28.48	2.54	2.03	4.58	0.51	1.02	2.54	1.53	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	28.02	5.35	2.04	1.78	0.51	2.55	1.02	1.78	1.02	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	24.78	1.91	0.64	0.64	1.91	1.27	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	28.91	3.88	1.73	3.88	1.73	1.73	0.86	1.29	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.67	2.12	1.48	2.96	0.42	1.69	0.64	0.42	0.85	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	22.91	1.16	1.45	1.45	1.74	2.03	0.29	0.87	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	39.68	4.72	0.00	3.78	0.94	0.94	3.78	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	28.14	3.56	2.54	4.41	1.53	1.70	1.02	0.85	0.85	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	0.00	0.00	0.00	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	0.00	2.11	6.34	0.00	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	30.23	2.14	1.29	2.36	1.07	2.36	1.07	1.93	0.64	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.66	1.20	0.60	2.41	0.00	2.41	0.00	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	23.33	2.19	1.46	2.19	0.73	0.73	0.00	1.46	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	28.97	2.76	1.38	2.07	2.07	2.76	0.69	1.15	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	0.00	2.55	5.10	0.00	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	22.88	1.02	2.29	1.78	1.27	3.05	2.03	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	36.13	2.89	2.27	4.75	1.45	1.03	0.41	1.03	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	28.76	1.53	0.92	4.59	1.22	2.75	0.92	0.92	1.53	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	39.68	2.39	0.48	0.96	0.00	1.43	1.43	2.39	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	29.71	2.00	1.77	2.44	2.00	1.11	1.33	1.77	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	19.84	3.05	1.53	6.10	1.53	0.00	0.00	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	31.02	0.55	1.11	4.98	0.00	1.11	0.00	2.22	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	26.48	2.91	0.79	3.44	3.71	2.12	0.53	0.79	1.32	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	24.35	0.36	2.18	2.18	1.09	1.45	0.73	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	76.27	7.25	8.11	3.81	1.60	4.54	1.35	2.33	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	72.91	8.04	6.33	1.03	0.86	1.20	0.86	0.68	1.20	0.68
Astrocyte - cerebellum, donor3	11661-122F5	58.94	2.94	4.61	3.36	2.31	3.78	2.52	1.05	0.42	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	47.76	3.49	3.49	2.09	2.09	2.79	2.09	1.39	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	66.00	6.15	3.40	1.78	3.40	2.43	0.49	0.81	0.97	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	66.38	4.33	4.03	1.49	1.94	2.68	1.49	0.60	0.75	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	109.52	2.87	7.57	0.57	1.26	0.69	1.15	0.34	3.44	2.06
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	113.51	3.51	9.15	0.88	1.63	0.50	0.88	0.13	3.13	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	99.00	2.16	7.28	1.14	1.48	0.34	0.68	0.23	1.59	1.37
Basophils, donor1	12241-129G9	43.94	1.05	4.45	1.05	5.75	0.00	2.88	1.31	0.00	0.00
Basophils, donor2	12242-129H1	52.32	0.00	1.44	2.16	1.44	0.36	1.44	0.72	0.36	0.00
Basophils, donor3	12243-129H2	59.83	1.91	1.91	2.20	3.23	0.00	3.82	1.18	0.59	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	45.06	4.10	1.94	1.51	1.72	1.29	1.08	0.86	1.08	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	82.75	6.40	4.11	2.29	1.83	1.83	0.91	0.00	1.37	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	0.00	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	46.45	4.39	1.26	2.51	1.88	1.26	1.26	3.14	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	64.26	4.37	3.95	1.25	1.25	0.21	2.50	1.46	0.21	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	64.02	3.45	2.30	2.30	1.84	1.84	1.38	0.92	0.69	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	33.47	4.32	1.08	1.08	1.44	0.72	0.72	0.36	0.54	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	98.83	0.52	4.23	0.10	1.13	0.10	0.52	0.00	1.13	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	67.31	0.93	1.63	0.00	0.47	0.00	0.23	0.23	0.47	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	65.55	1.60	2.88	0.96	0.96	0.96	0.32	0.32	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	0.00	20.68	10.34	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	80.59	1.69	1.69	3.94	3.94	0.56	0.56	2.25	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	72.38	1.48	2.78	3.34	1.86	0.00	0.37	1.48	2.04	0.74
CD14+ Monocytes, donor3	11381-118B4	77.28	1.76	2.41	1.76	3.07	0.00	0.88	1.10	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	78.40	1.98	1.98	5.38	1.42	0.57	0.85	1.13	1.13	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	55.72	2.27	3.03	7.58	1.90	0.00	3.03	1.14	1.14	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	69.36	3.94	1.97	4.27	1.64	0.00	0.33	1.31	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	63.75	1.73	4.19	3.04	2.75	0.14	2.02	1.16	1.16	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	55.52	0.60	3.02	1.81	2.72	0.00	1.81	1.51	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	52.35	0.71	2.84	0.95	0.95	0.00	1.42	0.47	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	52.73	1.00	2.34	1.84	1.84	0.00	1.17	1.00	0.50	1.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	48.03	0.83	3.59	2.21	2.76	0.00	1.66	2.21	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	60.99	0.74	2.48	3.47	0.74	0.00	1.98	2.48	0.74	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	57.17	0.20	2.94	3.33	2.35	0.00	2.35	2.55	0.00	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	48.25	0.53	1.78	2.85	2.31	0.00	1.60	1.78	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	55.93	0.87	4.13	5.22	1.31	0.00	2.39	2.18	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	66.96	1.87	3.98	4.45	3.51	0.23	2.58	3.28	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	64.42	0.53	3.70	2.11	3.70	0.00	3.17	3.17	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	76.55	0.00	1.11	3.33	1.11	0.00	5.55	4.44	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	60.24	0.45	3.42	1.78	2.68	0.00	1.04	0.74	1.49	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	52.48	0.80	2.79	2.39	1.60	0.20	2.59	1.20	0.60	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	48.51	1.04	1.87	0.83	2.29	0.00	1.04	0.42	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	61.54	0.92	4.58	2.52	2.75	0.23	2.97	2.06	1.60	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	44.11	0.45	4.30	3.17	2.71	0.23	2.26	1.58	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	65.47	1.31	3.49	3.93	4.36	0.00	3.49	1.75	0.44	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	53.26	1.34	2.96	2.15	1.88	0.00	1.88	1.08	0.54	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	57.57	1.05	2.97	1.74	1.92	0.00	0.52	0.87	0.52	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	58.49	0.84	3.37	2.10	0.42	0.00	1.26	0.42	0.42	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	69.44	1.10	3.67	3.49	1.84	0.00	1.65	1.29	0.73	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	44.74	0.70	2.11	3.87	3.87	0.00	2.47	2.47	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	77.65	0.88	4.83	3.51	1.75	0.00	1.32	1.32	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	51.27	0.70	3.84	2.44	1.05	0.00	2.44	1.22	0.52	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	55.01	1.12	3.72	3.72	1.86	0.00	1.49	1.86	0.74	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	54.10	0.43	2.59	3.88	1.72	0.00	2.16	2.59	0.43	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	58.97	1.64	2.05	2.87	2.87	0.00	0.82	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	40.80	0.70	3.94	4.40	4.64	0.00	3.94	1.62	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	51.97	0.23	4.41	3.02	2.78	0.00	1.16	1.86	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	58.20	1.09	3.92	0.87	1.74	0.00	1.31	0.22	0.44	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	63.52	1.39	2.77	1.85	2.54	0.00	1.39	0.69	0.46	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	46.57	0.43	1.30	0.65	1.08	0.00	0.65	0.43	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	77.55	0.78	3.11	1.09	2.02	0.00	1.25	0.47	0.47	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	75.97	1.05	3.67	1.57	1.57	0.00	0.87	0.17	0.35	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	69.79	2.45	3.12	1.34	1.56	0.45	1.11	0.22	0.45	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	55.63	0.00	2.30	0.26	2.55	0.00	1.28	0.26	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	61.92	2.42	2.42	0.88	1.76	0.00	1.32	0.44	0.22	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	63.16	1.47	2.95	0.42	1.26	0.21	1.26	0.42	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	54.87	10.16	0.00	0.00	0.00	0.00	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	60.34	3.39	2.71	0.00	2.03	0.68	0.00	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	63.17	2.07	3.11	1.04	1.04	0.00	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	70.89	3.20	2.67	1.07	0.00	1.07	0.53	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	81.48	3.22	6.97	1.61	1.61	0.00	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	68.09	3.51	2.81	0.00	2.11	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	57.26	1.57	4.71	1.57	2.35	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	43.50	3.95	7.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	56.71	3.29	6.58	0.00	3.29	0.00	0.00	0.00	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	64.56	0.00	0.73	0.73	0.73	0.00	0.73	0.73	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	60.07	1.51	4.04	0.50	0.50	0.00	0.50	0.00	1.01	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	109.10	9.70	4.04	0.81	1.21	1.21	0.81	0.00	1.62	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	80.70	2.80	8.39	1.20	1.60	0.40	1.20	0.00	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	41.17	3.01	2.01	6.02	2.01	0.00	0.00	3.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	56.18	3.93	2.25	1.12	1.12	0.00	0.56	2.25	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	65.38	4.13	3.38	1.13	1.88	1.50	0.38	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	59.30	1.80	6.31	1.13	0.90	1.80	0.68	0.00	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	86.41	3.21	7.14	1.07	3.21	0.36	1.43	0.00	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	83.89	1.22	3.06	2.45	1.84	0.61	0.00	0.00	1.84	3.06
CD4+ T Cells, donor3	11382-118B5	76.55	1.83	3.66	1.83	1.83	0.61	2.13	0.00	1.22	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	52.07	1.28	4.34	4.08	2.81	0.26	1.53	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	56.60	2.25	3.82	4.27	0.90	0.90	0.90	0.67	0.67	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	50.31	1.72	3.45	4.02	2.30	0.86	0.29	0.57	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	65.42	1.90	6.16	0.95	1.42	0.00	0.95	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	68.83	1.40	4.21	2.11	2.11	0.70	1.40	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	102.18	0.00	3.30	0.00	0.00	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	51.88	0.58	2.75	2.89	2.31	0.00	0.58	0.58	0.14	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	52.19	2.20	3.05	5.93	2.71	0.68	0.51	0.85	0.51	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	47.56	1.77	2.90	4.19	1.93	0.64	0.81	0.64	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	49.76	1.34	4.48	0.45	0.45	0.90	1.79	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	53.11	1.40	2.45	0.35	2.10	0.00	0.35	0.35	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	61.60	3.52	5.28	1.32	2.20	0.88	0.88	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	90.65	0.00	2.53	1.26	0.42	0.42	0.42	0.00	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	71.89	0.62	4.16	1.45	1.45	0.21	0.42	0.21	0.83	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	57.47	0.67	2.67	2.67	1.00	0.67	0.33	0.00	1.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	105.51	1.09	8.70	0.54	1.63	0.00	1.90	0.00	1.09	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	101.29	2.14	2.68	0.00	1.07	0.54	1.07	0.00	1.07	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	129.11	1.79	7.17	0.00	0.00	0.00	1.79	0.00	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	88.82	1.11	5.19	1.85	0.56	0.93	0.56	0.74	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	73.22	1.08	4.33	1.30	1.30	0.87	0.22	0.22	0.87	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	73.34	0.63	3.36	1.89	1.68	0.42	1.05	0.21	0.63	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	59.16	1.01	4.04	0.51	0.51	0.00	1.01	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	59.79	2.17	3.03	0.43	3.03	0.43	0.87	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	75.83	3.92	7.84	0.44	3.49	0.87	0.44	0.00	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	72.25	2.97	3.96	0.49	1.98	0.49	1.48	0.00	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	73.85	0.92	5.54	0.00	0.92	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	57.23	1.40	1.40	0.00	2.79	0.00	2.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	90.00	2.77	3.88	0.83	1.38	1.11	0.83	0.00	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	95.46	4.17	6.13	2.21	1.96	0.49	1.72	0.00	0.74	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	89.32	0.00	1.54	3.08	1.54	1.54	1.54	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	92.39	2.86	8.59	1.07	1.43	0.00	1.43	0.00	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	59.55	0.00	2.77	1.38	1.38	0.00	4.15	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	73.99	0.98	5.89	0.65	1.96	0.00	1.96	0.65	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	62.32	1.50	3.75	1.13	2.25	0.38	2.25	0.00	1.50	0.75
CD8+ T Cells, donor3	11383-118B6	84.08	1.51	5.05	0.76	2.02	1.01	1.77	0.00	0.76	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	69.51	1.15	1.61	0.92	1.61	0.00	0.46	1.61	0.69	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	69.02	0.24	3.59	4.55	0.48	0.72	0.48	0.24	0.96	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	57.18	0.55	3.01	2.19	1.09	1.92	0.82	0.55	1.64	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	66.35	1.80	3.00	2.70	0.30	1.20	0.60	1.50	1.80	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	67.68	0.24	1.92	1.44	0.00	0.48	1.20	0.96	1.20	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	61.62	0.23	1.82	2.27	0.91	0.45	0.23	1.14	0.91	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	80.40	1.30	4.35	1.30	0.00	1.30	0.43	0.22	0.43	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	76.07	0.00	2.63	0.79	0.26	0.26	0.79	0.26	1.05	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	80.44	1.17	4.46	1.41	0.23	1.17	0.47	0.70	0.47	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	71.54	0.91	5.43	0.60	0.30	0.30	0.91	0.91	0.91	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	73.21	1.16	3.78	3.20	0.87	0.00	0.87	0.29	0.87	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	85.53	1.07	3.20	1.60	0.53	0.53	1.07	1.60	1.07	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	65.66	0.44	2.19	2.19	0.00	0.44	0.44	2.19	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	59.21	1.82	2.73	2.73	0.46	0.91	0.91	1.82	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	44.75	1.49	1.49	0.75	0.00	0.75	0.75	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	81.40	0.72	5.04	3.60	0.36	0.36	0.00	2.16	0.36	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	61.57	1.44	2.88	2.88	0.29	0.58	1.15	1.73	1.73	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	63.17	0.47	3.77	2.12	0.24	0.24	0.71	1.41	1.18	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	101.73	0.00	3.49	1.58	0.95	0.32	0.63	0.95	1.58	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	89.50	0.62	3.38	1.23	0.31	0.31	0.62	0.00	0.92	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	95.85	3.21	2.89	1.92	0.32	0.64	0.96	0.32	0.64	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	58.52	1.15	4.21	1.53	1.15	0.38	0.76	0.76	0.76	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	73.70	0.39	1.58	2.36	0.39	1.18	1.97	0.79	1.18	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	70.35	1.51	1.51	1.51	0.00	1.51	0.00	0.76	0.76	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	72.27	0.80	3.21	9.64	2.41	1.61	1.61	6.42	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	51.06	0.70	2.10	13.29	2.10	0.70	3.50	6.99	2.10	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	78.14	3.01	4.01	13.02	1.00	0.00	0.00	8.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	18.28	3.66	3.66	3.66	0.00	3.66	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	41.50	1.98	1.98	4.94	1.48	0.49	0.00	0.49	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	38.52	1.79	2.21	1.16	1.05	1.37	0.84	0.63	0.32	0.11
Chondrocyte - de diff, donor1	11261-116G1	42.64	4.85	1.73	0.69	1.04	2.08	0.35	1.39	0.35	0.69
Chondrocyte - de diff, donor2	11338-117F6	39.80	2.13	0.71	1.42	0.36	0.71	2.49	0.36	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	34.93	2.05	2.39	2.84	1.71	1.59	0.80	1.82	1.59	0.23
Chondrocyte - re diff, donor2	11339-117F7	39.39	1.79	4.48	0.00	4.48	1.79	3.58	0.90	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	44.08	6.87	1.21	0.40	2.02	0.81	2.02	0.40	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	54.97	1.72	3.10	4.02	3.10	2.07	2.64	1.95	0.46	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	48.52	4.49	2.78	3.42	2.14	2.35	1.07	1.71	0.64	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	58.76	2.04	4.78	3.27	3.36	2.04	2.83	1.06	0.80	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	190.46	9.72	10.91	2.48	3.94	4.13	2.29	0.46	3.12	1.10
Corneal Epithelial Cells, donor1	11526-119I5	70.70	3.07	2.63	1.54	0.66	1.10	1.10	1.10	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	68.26	1.14	1.14	2.28	0.00	0.00	1.14	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	60.33	3.07	2.81	0.77	1.28	0.26	0.77	0.51	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	29.22	0.83	0.33	4.95	0.66	0.17	0.33	1.16	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	37.53	0.63	0.32	2.84	0.95	0.00	1.58	0.63	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	0.00	0.00	6.90	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	38.23	0.86	0.43	6.48	0.43	0.00	0.76	1.30	0.32	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	92.58	1.02	1.71	1.71	0.68	0.68	1.02	0.34	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	90.10	2.61	2.61	1.96	1.31	1.96	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	106.95	1.45	1.94	0.00	1.45	0.48	0.00	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	77.88	2.84	4.84	4.17	2.17	2.67	1.00	1.50	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	39.90	2.35	1.76	1.76	0.59	1.17	0.59	2.35	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	55.71	2.83	4.52	2.83	1.13	1.70	1.13	1.98	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	45.61	1.57	4.33	1.97	1.57	2.75	2.36	1.57	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	48.29	2.91	4.07	6.11	1.75	1.75	2.04	1.75	0.87	1.16
Endothelial Cells - Artery, donor2	11341-117F9	77.64	2.59	4.24	2.59	1.65	1.18	2.35	0.94	2.59	0.94
Endothelial Cells - Artery, donor3	11413-118E9	83.62	2.45	5.79	2.10	2.28	0.70	1.93	1.93	1.05	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	46.77	1.99	2.22	7.54	2.44	1.55	1.99	4.65	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	40.16	3.35	3.04	9.13	4.26	2.13	3.65	5.17	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	51.87	2.82	2.26	9.02	0.56	1.13	2.26	4.23	0.56	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	68.34	2.67	4.16	5.65	2.08	1.78	1.78	6.54	2.38	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	49.98	1.04	5.73	5.73	0.52	0.00	2.08	3.64	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	61.82	2.27	2.27	8.93	2.55	0.71	1.84	3.26	2.13	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	71.22	1.20	4.80	2.80	0.40	2.00	0.40	2.00	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	56.61	4.19	2.62	3.67	1.57	1.57	1.57	1.05	2.10	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	83.12	3.11	6.83	3.35	2.48	1.74	1.49	0.99	0.87	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	51.71	1.30	3.48	1.96	2.17	0.43	0.22	0.43	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	51.42	2.08	3.91	0.98	0.49	0.24	0.98	0.49	0.49	0.61
Endothelial Cells - Vein, donor1	11267-116G7	55.74	2.28	5.69	2.28	3.41	5.69	0.00	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	118.75	2.10	8.38	3.49	1.40	3.49	2.10	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	81.33	2.04	2.51	3.14	3.61	1.26	2.67	2.20	0.79	0.79
Eosinophils, donor1	12244-129H3	45.74	0.00	15.25	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	85.81	3.30	3.30	14.85	16.50	0.00	6.60	11.55	0.00	0.00
Eosinophils, donor3	12246-129H5	96.30	3.57	0.00	7.13	14.27	0.00	7.13	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	52.29	3.66	3.18	1.22	0.98	0.73	1.22	0.73	0.73	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	37.44	2.08	4.16	0.00	2.08	4.16	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	16.27	0.00	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	30.38	0.00	1.64	1.23	1.23	0.82	1.64	0.00	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	11.50	0.55	0.77	1.75	0.88	0.88	1.20	1.31	0.88	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	24.27	0.76	1.19	2.06	0.87	0.33	0.76	0.43	0.76	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	41.96	1.58	3.03	2.30	1.70	1.46	0.36	1.21	1.70	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	47.76	9.01	3.68	3.96	7.23	1.77	5.32	2.05	0.82	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	34.28	3.06	2.32	2.85	1.79	1.16	2.43	1.27	1.69	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	59.55	5.01	6.59	1.84	3.69	1.32	3.16	0.53	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	51.49	3.65	3.99	1.33	1.00	1.33	2.66	0.33	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	34.93	4.99	2.27	3.18	1.36	0.91	1.36	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	68.97	3.03	3.03	0.00	0.00	2.27	5.31	0.76	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	45.42	2.68	1.42	2.37	1.42	0.95	1.42	1.42	1.58	0.32
Fibroblast - Cardiac, donor4	11452-119A3	48.50	2.42	3.03	1.82	0.30	0.91	0.30	0.91	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	49.62	2.92	2.66	2.92	0.76	1.14	0.76	1.65	0.76	0.63
Fibroblast - Cardiac, donor6	11460-119B2	47.15	0.45	1.97	0.30	0.15	0.45	0.61	0.45	0.30	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	55.61	5.76	5.36	3.89	1.34	3.89	1.47	1.74	0.40	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	42.71	1.73	2.16	4.31	0.00	1.73	0.43	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	51.27	1.46	4.39	0.00	0.00	1.46	0.00	1.46	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	94.79	3.92	6.92	3.00	1.38	1.15	1.85	1.38	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	39.86	4.24	3.22	9.50	4.24	4.07	2.54	3.39	1.19	0.17
Fibroblast - Dermal, donor1	11269-116G9	38.50	3.29	1.17	4.93	1.41	0.23	1.17	1.17	0.94	0.94
Fibroblast - Dermal, donor2	11346-117G5	57.07	2.83	4.25	1.89	0.94	1.89	2.36	0.94	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	46.54	1.33	2.18	2.54	1.69	0.24	1.57	0.97	1.45	0.24
Fibroblast - Dermal, donor4	11450-119A1	50.76	3.05	2.94	1.58	0.79	0.90	1.02	0.11	0.34	0.57
Fibroblast - Dermal, donor5	11454-119A5	60.36	2.97	2.27	1.92	0.70	1.40	0.70	0.35	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	62.70	2.76	4.06	0.97	0.81	0.49	0.81	0.16	0.65	0.65
Fibroblast - Gingival, donor1	11237-116D4	44.77	1.46	2.08	5.21	1.04	1.04	1.46	1.67	0.42	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	43.49	2.62	2.10	3.93	0.79	3.41	2.10	1.05	1.05	0.52
Fibroblast - Gingival, donor2	11318-117D4	56.54	3.16	4.35	2.77	1.32	0.66	1.32	1.19	1.19	0.79
Fibroblast - Gingival, donor3	11394-118C8	45.06	2.80	1.35	5.90	0.87	1.06	1.35	1.45	1.35	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	44.67	7.27	0.00	3.12	5.19	0.00	3.12	4.16	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	31.72	3.70	1.06	2.82	0.88	1.76	0.53	1.23	1.06	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	58.77	1.87	2.18	1.56	1.56	1.09	0.31	0.78	0.62	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	40.43	2.16	2.03	3.65	0.81	2.70	0.95	0.81	0.81	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	67.40	1.76	2.82	2.12	0.35	2.47	0.71	2.12	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	47.24	1.61	2.63	2.34	1.17	2.05	0.44	1.61	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	42.27	2.45	2.73	2.32	1.91	1.36	0.68	0.27	0.82	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	47.17	2.30	2.85	1.43	0.99	0.99	0.33	0.44	0.22	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	26.41	2.64	1.17	4.99	2.20	2.05	1.17	0.88	0.29	0.44
Fibroblast - Lung, donor1	11270-116H1	73.40	8.16	1.36	2.72	0.00	1.36	4.08	4.08	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	61.18	2.98	4.48	2.98	2.98	1.49	0.00	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	63.10	3.38	2.95	4.22	0.84	0.84	1.69	0.84	2.53	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	124.12	6.66	10.00	2.50	3.33	3.33	5.83	1.67	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	34.97	8.39	2.80	5.59	1.40	1.40	2.80	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	48.98	2.24	3.08	1.96	1.96	1.96	1.12	0.56	0.56	0.28
Fibroblast - Mammary, donor1	11540-120B1	108.39	4.87	6.09	3.25	0.81	1.62	2.03	0.81	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	123.82	0.00	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	5.96	5.96	5.96	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	53.34	2.13	3.69	2.72	2.13	0.19	1.16	1.36	0.78	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	69.77	4.70	5.61	3.79	1.21	1.52	0.91	0.76	1.21	1.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	43.14	2.75	1.53	2.75	0.92	2.14	1.22	0.61	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	34.35	4.20	1.53	1.14	0.76	1.91	0.38	0.76	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	31.59	2.16	2.16	1.35	1.08	0.81	0.81	1.08	0.81	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	35.72	2.44	1.74	2.78	0.58	0.70	0.70	0.81	0.70	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	42.00	1.66	2.87	0.99	0.99	0.88	0.77	0.44	0.33	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	93.26	2.84	6.91	2.64	3.66	1.22	3.25	0.20	0.81	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	82.86	7.35	1.34	0.00	2.00	1.34	1.34	2.00	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	40.33	1.19	1.98	1.58	0.79	0.40	0.79	0.79	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	84.54	5.56	4.76	1.59	0.79	2.38	0.79	0.40	1.59	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	34.99	3.20	1.95	2.84	0.53	0.89	0.36	0.36	1.07	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	30.94	1.97	1.97	1.97	0.99	1.77	0.99	0.20	0.79	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	83.64	8.42	4.81	0.90	2.11	2.11	1.50	0.60	0.60	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	37.14	7.12	2.59	2.27	1.19	2.59	1.62	0.43	0.22	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	93.13	7.59	5.82	1.27	1.77	2.02	1.52	0.25	0.51	0.76
Fibroblast - skin normal, donor1	11553-120C5	41.02	2.95	1.15	1.80	0.49	1.64	0.98	1.15	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	84.61	9.42	5.81	1.20	3.41	2.41	3.01	1.00	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	43.60	4.82	2.41	0.80	2.21	1.71	1.41	0.60	0.30	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	106.09	15.11	7.56	1.81	4.23	3.02	3.02	0.60	0.30	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	31.90	2.15	1.33	3.31	1.49	1.41	0.50	0.99	0.33	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	37.44	5.81	2.74	5.30	1.88	1.88	2.39	2.56	0.34	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	87.36	7.23	4.60	2.96	4.60	1.97	3.28	1.64	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	43.57	5.75	2.34	3.30	1.70	0.96	1.49	1.07	0.21	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	52.29	3.37	3.88	2.53	1.01	1.86	1.18	0.84	1.01	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	27.44	1.88	1.41	3.14	1.10	0.94	0.63	1.25	1.88	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	22.16	0.00	0.00	44.32	0.00	0.00	44.32	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	37.48	1.74	2.61	1.74	2.61	0.00	0.87	2.61	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	34.15	3.81	0.52	2.08	2.08	2.77	0.87	2.43	0.35	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	39.82	4.16	2.34	3.38	0.52	2.08	0.26	1.56	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	34.49	2.30	1.79	1.28	1.28	1.28	1.28	1.02	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	69.67	2.30	8.42	3.06	1.53	1.53	0.00	1.53	3.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	67.64	1.91	7.02	1.28	2.55	3.19	0.64	1.28	1.91	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	76.45	8.27	5.42	5.13	1.43	3.42	1.71	2.57	1.43	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	77.76	12.96	2.76	6.34	6.07	3.03	1.65	2.48	6.07	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	45.21	6.85	3.20	6.62	4.79	3.65	2.05	4.79	2.28	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	64.19	7.53	3.76	4.36	2.77	2.97	1.39	2.77	1.78	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	65.56	8.72	2.38	4.76	5.55	2.64	1.59	5.02	3.17	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	52.84	5.54	2.28	4.89	3.59	4.24	2.28	4.89	1.30	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	49.09	4.86	5.31	1.77	1.77	0.44	1.33	1.77	2.21	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	102.60	7.77	4.10	7.21	2.12	1.98	0.85	2.69	2.97	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	91.49	7.02	4.56	7.27	1.85	2.71	0.62	5.17	3.45	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	61.52	6.98	2.95	5.10	1.61	1.34	1.07	2.95	3.22	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	104.81	6.69	5.20	7.93	1.86	2.60	1.24	4.96	3.47	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	105.07	8.03	3.88	7.20	1.25	1.80	0.97	5.68	3.05	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	60.18	4.47	3.05	7.12	1.02	2.24	0.41	4.47	3.25	2.44
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	76.67	4.34	4.34	7.76	3.19	2.51	1.37	5.48	4.34	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	94.67	6.23	2.87	11.83	2.62	2.49	1.99	6.23	2.99	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	69.94	5.68	2.84	10.05	1.75	2.19	0.87	6.56	1.09	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	73.28	4.14	1.18	7.98	3.84	3.84	2.36	3.25	4.14	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	103.32	6.99	3.50	8.90	1.75	1.75	1.59	3.81	3.02	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	75.07	6.48	2.90	7.15	1.56	2.68	1.34	3.57	1.79	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	81.66	4.03	4.64	9.07	2.82	2.02	1.61	2.42	4.64	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	106.87	5.60	5.26	9.16	3.56	2.37	1.53	5.09	5.43	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	91.69	4.52	4.26	11.08	4.61	3.46	2.22	7.27	1.86	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	135.17	6.87	5.51	15.92	6.56	3.12	3.02	6.66	4.27	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	136.11	7.68	5.64	12.98	4.61	4.61	1.54	5.29	2.90	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	97.82	6.09	3.32	8.30	1.99	2.32	1.66	2.77	3.10	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	79.20	4.58	3.49	7.40	3.33	1.91	2.08	4.33	3.00	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	76.16	3.27	6.33	5.92	2.45	0.82	1.84	3.06	1.84	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	70.76	5.98	1.65	10.11	1.44	2.68	1.24	4.75	2.68	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	104.46	7.38	4.15	8.42	3.00	2.08	1.84	3.80	3.34	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	77.71	4.17	2.84	4.67	3.17	0.67	1.50	2.17	3.00	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	82.22	5.07	4.19	9.92	2.65	3.53	2.20	3.31	3.31	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	109.09	7.26	3.57	9.72	2.83	2.95	2.83	5.41	6.15	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	70.35	4.54	3.24	3.89	1.46	2.43	2.11	3.40	3.08	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	85.31	5.13	2.89	9.62	4.17	2.25	2.57	4.49	3.85	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	88.12	5.31	4.45	6.35	2.18	2.37	1.42	2.56	3.03	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	69.91	3.16	4.27	5.69	2.53	1.42	1.58	2.37	2.85	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	74.50	1.22	2.43	7.60	2.74	1.82	2.43	5.17	3.04	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	96.18	5.65	4.18	6.48	2.40	2.93	1.78	3.76	2.61	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	60.38	0.66	1.98	7.25	2.63	0.66	1.10	1.54	1.98	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	74.06	5.61	3.93	8.70	2.81	2.81	1.68	2.81	5.33	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	74.72	4.44	3.33	6.76	2.22	2.04	1.94	3.43	1.48	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	54.82	3.21	4.28	5.35	1.34	1.60	1.60	2.14	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	69.31	3.37	3.21	7.34	1.84	2.14	1.99	3.21	1.99	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	76.69	2.46	4.27	5.44	1.55	2.46	1.42	2.20	1.68	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	63.16	5.15	4.07	4.34	1.36	2.44	0.54	1.36	2.44	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	49.59	3.50	2.77	7.37	2.21	3.87	2.40	2.03	1.47	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	47.81	5.04	3.07	7.02	3.29	2.63	1.32	1.97	1.54	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	71.41	5.95	4.96	2.98	5.95	3.97	2.98	3.97	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	53.56	3.17	3.03	5.94	1.19	1.98	2.37	1.45	2.37	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	48.02	2.22	1.41	5.25	3.03	1.61	1.82	2.42	2.82	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	105.22	7.62	5.59	19.32	9.66	10.17	6.10	7.12	3.30	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	84.60	18.31	5.37	3.38	1.59	2.79	1.19	4.18	2.79	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	87.36	8.94	5.55	5.39	1.54	2.47	0.62	3.24	2.93	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	116.41	12.68	4.91	4.30	1.43	2.05	0.20	2.66	2.66	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	59.77	1.88	2.82	2.82	1.56	2.19	0.00	0.31	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	54.82	3.39	4.52	3.11	2.26	2.26	0.00	1.98	0.85	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	58.11	6.46	2.31	4.15	1.84	2.77	1.84	5.53	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	71.77	9.90	4.95	12.37	0.00	2.47	0.00	2.47	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	66.53	4.64	5.42	5.42	2.32	2.71	2.71	3.09	1.93	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	68.99	1.60	4.81	4.81	3.21	3.21	0.00	3.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	76.51	1.74	1.74	6.96	1.74	1.74	1.74	3.48	3.48	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	55.33	3.58	1.63	5.53	2.28	1.63	1.63	3.91	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	60.53	3.71	2.47	6.18	1.24	4.53	1.24	2.88	1.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	56.65	6.66	3.33	6.66	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	57.33	4.47	4.75	4.47	1.68	3.08	0.56	1.68	0.84	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	62.10	3.92	3.92	7.19	1.31	1.96	0.33	1.63	2.29	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	67.11	5.03	5.03	5.03	0.84	5.03	0.84	1.68	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	61.07	4.13	2.54	5.41	2.54	2.86	0.64	1.27	1.59	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	66.57	2.72	3.06	7.13	1.70	2.38	0.68	2.72	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	50.12	4.18	2.09	0.00	2.09	4.18	2.09	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	75.02	6.30	1.72	6.87	1.72	1.15	1.72	2.86	2.29	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	65.71	3.85	1.48	5.62	1.18	3.26	1.18	2.07	1.78	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	59.30	3.39	3.39	5.08	1.69	0.00	0.00	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	63.79	5.38	4.56	5.38	2.07	3.31	1.66	4.14	0.41	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	74.33	2.99	3.68	4.60	1.38	2.76	1.38	3.91	1.61	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	0.00	0.00	0.00	0.00	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	53.05	3.46	3.08	2.69	1.15	3.08	1.15	4.23	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	51.18	3.26	2.61	4.56	1.96	2.61	1.30	2.28	1.30	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	34.11	0.00	0.67	4.68	0.67	2.01	0.67	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	57.02	5.01	1.93	5.01	1.93	2.70	1.16	1.93	1.54	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	66.41	5.48	3.08	3.42	1.37	4.11	1.03	3.42	1.37	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	37.27	7.45	2.48	17.39	0.00	2.48	2.48	4.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	60.40	3.77	1.89	7.55	0.00	3.77	2.36	0.94	0.47	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	52.50	4.22	1.21	6.64	1.21	1.21	0.60	1.81	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	52.39	2.03	1.53	5.60	0.00	1.02	1.53	2.54	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	55.84	4.39	1.60	3.99	2.39	2.79	1.60	1.20	1.99	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	52.30	4.93	1.48	6.41	2.47	2.96	0.99	3.45	1.97	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	63.74	7.08	2.36	8.26	1.18	3.54	1.18	0.00	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	54.84	5.83	2.33	5.25	1.17	4.08	0.58	0.58	1.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	61.88	7.46	0.88	5.27	1.76	3.07	1.32	1.76	1.32	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	44.93	2.54	4.24	4.24	1.70	0.00	0.00	2.54	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	38.80	2.98	0.00	3.58	5.97	4.78	0.60	5.97	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	50.47	0.97	1.94	4.37	0.97	2.43	0.97	3.88	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	60.49	5.71	2.28	0.00	1.14	0.00	1.14	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	40.33	2.08	2.49	3.33	1.25	1.25	1.25	1.66	3.74	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	76.46	2.25	9.00	5.62	2.25	2.25	2.25	0.00	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	30.45	0.63	2.22	2.85	0.95	0.95	0.00	0.63	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	18.38	1.25	0.00	3.76	0.42	2.92	0.42	1.25	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	87.61	1.04	4.87	0.70	1.28	1.51	0.93	0.70	2.67	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	106.01	0.84	7.60	0.84	2.19	1.69	1.52	1.69	3.54	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	91.00	0.68	6.37	0.68	1.14	1.14	1.59	1.59	1.37	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	91.16	1.31	7.65	0.55	1.86	1.31	0.87	0.87	1.53	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	99.07	0.86	7.09	0.86	1.29	0.86	2.79	0.64	1.50	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	84.18	1.29	5.60	2.37	1.08	1.72	1.29	0.43	1.29	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	89.92	1.00	7.10	0.75	1.62	1.12	1.74	0.75	2.24	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	95.90	1.37	5.66	0.51	1.03	0.51	1.54	0.86	1.72	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	87.78	1.28	3.52	0.96	2.56	0.64	1.28	0.64	1.28	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	76.67	5.04	4.48	2.24	2.80	0.56	0.56	1.12	0.56	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	101.27	1.73	2.16	3.90	3.03	1.73	1.30	1.30	2.16	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	0.00	2.64	2.64	2.64	2.64	0.00	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	62.78	3.17	3.53	1.41	0.71	2.82	0.35	1.41	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	59.57	2.91	5.09	2.18	2.18	2.18	0.73	0.00	1.45	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	44.58	1.05	3.15	0.52	1.22	0.35	0.87	0.00	1.22	0.17
Hepatocyte, donor1	11523-119I2	62.95	0.00	4.84	3.63	2.42	2.42	6.05	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	72.18	1.08	5.39	2.15	6.46	0.00	2.15	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	57.67	2.45	2.45	1.84	4.91	0.61	1.84	1.23	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	134.45	0.65	7.83	0.65	0.00	1.96	0.65	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	88.61	2.45	4.54	7.52	3.67	2.45	4.54	7.52	0.87	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	40.61	2.88	2.06	3.43	2.74	2.74	1.92	0.41	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	219.69	0.00	9.55	3.18	3.18	3.18	3.18	0.00	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	193.58	0.00	20.03	0.00	0.00	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	196.58	1.38	16.61	2.77	0.00	2.77	1.38	1.38	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	327.85	2.50	15.02	0.00	0.00	0.00	0.00	0.00	5.01	7.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	154.29	0.00	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	243.48	10.25	15.38	2.56	5.13	0.00	2.56	5.13	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	237.68	4.57	9.14	0.00	0.00	0.00	0.00	0.00	4.57	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	303.75	3.25	21.12	4.87	4.87	1.62	3.25	0.00	6.50	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	225.09	1.67	20.01	1.67	5.00	0.00	3.33	0.00	6.67	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	246.88	3.63	7.26	3.63	3.63	3.63	3.63	0.00	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	258.08	1.32	13.23	1.32	1.32	1.32	2.65	0.00	9.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	246.12	5.54	8.87	1.11	2.22	4.43	2.22	0.00	0.00	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	272.39	5.24	15.71	0.00	0.00	0.00	0.00	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	221.71	3.15	9.45	2.52	0.63	2.52	2.52	1.26	2.52	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	228.90	4.64	13.92	1.55	7.73	0.00	7.73	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	190.25	0.00	14.63	0.00	0.00	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	292.01	1.94	10.98	2.58	6.46	1.94	3.23	0.00	5.17	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	246.32	4.83	16.10	0.00	1.61	3.22	3.22	0.00	4.83	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	286.76	0.00	11.95	0.00	11.95	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	303.95	4.07	15.48	2.44	0.81	1.63	0.81	0.81	5.70	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	263.64	2.10	16.37	0.42	4.62	2.10	5.88	0.42	2.52	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	229.96	0.00	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	262.00	1.61	16.88	3.21	1.61	0.00	2.41	0.80	2.41	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	192.04	2.77	12.93	0.92	2.77	0.92	0.92	0.00	0.92	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	211.13	0.00	15.08	0.00	0.00	15.08	0.00	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	227.52	0.94	14.16	1.42	0.94	0.00	1.42	1.42	4.25	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	159.63	1.81	10.88	0.00	1.81	0.91	1.81	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	294.85	14.74	0.00	0.00	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	309.92	3.23	19.37	2.15	1.08	0.00	3.23	1.08	3.23	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	259.17	2.54	13.98	2.54	3.81	2.54	1.27	0.00	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	180.73	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	302.90	2.55	10.84	3.83	5.74	2.55	3.19	1.28	5.74	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	258.82	0.00	10.94	3.65	3.65	3.65	0.00	0.00	3.65	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	310.62	2.14	17.14	1.43	2.14	0.71	1.43	0.71	6.43	4.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	258.83	6.64	16.59	0.00	9.95	0.00	3.32	3.32	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	166.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	214.83	1.23	10.80	1.23	2.78	0.93	3.09	0.62	4.63	2.16
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	203.70	1.76	14.05	1.76	8.78	1.76	5.27	0.00	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	207.45	0.00	15.72	0.00	0.00	3.14	9.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	217.66	0.70	12.52	0.70	1.39	0.70	2.09	0.70	4.87	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	316.47	4.43	13.28	0.00	4.43	2.21	0.00	0.00	8.85	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	262.60	3.24	29.18	0.00	0.00	0.00	3.24	0.00	9.73	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	354.00	2.62	6.10	1.74	2.62	0.87	0.87	1.74	6.98	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	359.97	0.00	9.00	4.50	0.00	4.50	0.00	0.00	6.75	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	306.64	0.00	10.45	3.48	0.00	0.00	10.45	0.00	0.00	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	430.98	2.13	10.67	2.13	5.33	1.07	2.13	2.13	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	229.98	4.16	9.70	0.00	0.00	0.00	4.16	0.00	1.39	4.16
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	196.62	2.85	17.10	0.00	2.85	0.00	2.85	2.85	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	294.54	0.92	12.89	2.76	3.68	1.84	2.76	0.92	7.36	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	248.08	0.00	9.08	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	279.39	0.00	6.21	12.42	0.00	0.00	0.00	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	352.10	3.17	15.86	4.23	4.23	0.00	3.17	1.06	8.46	0.00
Keratinocyte - epidermal, donor1	11272-116H3	37.62	2.37	2.20	4.08	3.02	2.77	2.12	3.02	1.39	0.65
Keratinocyte - epidermal, donor2	11349-117G8	65.01	4.69	0.59	0.00	3.51	0.59	0.59	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	46.67	3.79	2.65	0.85	0.57	0.76	0.66	0.28	0.85	0.09
Keratinocyte - oral, donor1	11251-116E9	68.22	6.02	2.50	2.84	1.36	2.16	0.79	0.68	1.59	0.57
Keratocytes, donor1	11527-119I6	93.87	1.72	2.06	5.50	3.44	0.69	6.19	4.47	1.38	0.00
Keratocytes, donor2	11607-120I5	60.93	2.34	3.52	1.17	0.00	2.34	0.00	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	41.30	1.78	0.79	3.75	2.17	0.99	1.98	1.19	0.59	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	46.16	0.00	4.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	47.46	0.00	2.16	2.16	1.08	4.31	1.08	2.16	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	54.90	9.23	2.54	6.92	4.04	5.77	3.92	4.38	0.69	0.12
Lens Epithelial Cells, donor3	11690-122I7	30.88	5.85	2.32	3.63	1.72	4.64	2.32	1.51	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	68.18	2.25	6.88	8.30	2.61	0.95	2.13	5.93	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	66.98	1.12	6.42	4.47	0.56	0.56	0.56	1.67	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	67.21	1.10	3.31	7.56	0.79	0.79	1.42	3.78	1.10	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	55.92	1.61	4.84	4.30	2.15	1.08	0.54	2.15	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	55.15	1.58	3.47	5.99	0.95	0.63	0.95	3.15	1.26	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	68.89	1.51	3.99	9.16	1.83	0.32	1.83	3.99	2.05	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	63.20	0.41	3.28	4.10	0.41	0.00	1.23	3.28	1.23	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	66.24	0.76	2.02	7.33	1.77	0.51	1.52	2.02	1.52	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	57.43	1.41	4.64	7.32	2.67	0.99	2.96	4.50	2.82	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	54.98	0.40	3.56	4.35	1.98	1.19	1.19	3.16	0.40	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	53.51	0.58	2.13	3.68	1.36	0.58	1.36	0.78	1.94	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	69.99	0.93	5.00	7.78	1.48	0.19	1.30	3.15	0.93	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	58.54	0.70	4.18	5.57	2.44	0.35	0.35	1.39	1.05	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	64.64	0.95	4.53	3.82	0.95	0.72	1.19	1.43	1.19	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	64.97	1.10	6.04	7.55	2.20	0.69	2.06	3.57	1.65	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	58.82	0.62	3.08	7.08	1.85	0.62	1.23	2.46	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	64.22	1.25	4.99	4.36	1.56	0.00	0.94	2.49	0.94	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	79.05	2.01	5.12	7.14	2.38	1.10	2.20	5.12	1.65	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	61.54	0.33	4.61	4.94	1.32	0.33	1.32	3.95	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	68.82	1.17	6.74	6.44	1.46	0.00	1.46	2.05	1.46	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	72.44	1.74	4.98	9.21	1.24	0.50	2.49	4.98	1.00	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	62.08	1.94	2.42	2.91	1.45	1.45	0.97	1.94	2.42	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	61.13	0.27	4.58	2.69	1.89	0.54	0.81	2.15	1.89	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	64.03	1.51	3.18	7.87	2.27	0.30	2.57	3.03	1.82	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	62.73	0.52	1.56	3.63	1.56	0.52	2.07	2.07	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	62.40	0.84	3.56	2.93	1.05	1.26	1.05	0.84	1.05	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	67.07	1.05	3.16	6.77	2.11	1.35	1.80	3.16	2.26	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	63.97	1.38	4.82	4.13	2.75	1.38	1.38	4.13	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	56.44	0.56	1.88	3.39	2.07	0.75	1.88	1.32	2.63	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	64.68	1.59	4.56	9.12	2.01	0.85	1.91	4.56	2.23	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	52.82	0.48	3.88	4.36	0.97	0.00	0.48	2.42	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	58.55	1.98	2.65	4.30	1.32	0.33	0.99	2.98	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	64.92	1.61	3.84	9.54	1.61	0.74	1.61	6.44	2.11	0.87
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	64.79	0.37	3.70	8.14	1.11	0.74	3.70	6.29	1.11	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	55.35	0.00	4.45	2.96	0.99	0.49	0.99	2.22	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	58.16	1.37	6.74	8.25	1.79	0.41	1.24	4.40	1.37	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	54.68	2.25	3.54	3.54	1.93	0.00	0.96	3.22	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	60.26	0.00	3.65	6.39	1.22	0.61	1.22	2.13	0.91	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	65.50	1.12	3.64	8.12	2.10	0.42	0.84	3.92	1.26	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	54.40	0.71	2.84	6.04	0.71	1.42	0.71	3.20	1.07	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	70.78	0.48	4.85	3.88	0.48	0.48	0.97	1.94	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	72.82	1.09	5.45	7.31	2.80	0.78	1.71	4.98	1.24	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	49.78	1.43	2.51	5.01	0.72	0.36	1.43	2.86	0.72	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	65.01	1.31	3.92	3.59	0.98	0.33	0.98	2.29	1.31	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	66.62	1.88	4.24	8.48	3.53	1.41	1.18	5.41	1.88	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	74.00	1.36	4.95	8.66	1.86	1.11	2.35	4.33	0.99	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	70.69	0.26	3.84	2.56	2.05	0.51	0.77	1.79	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	64.15	1.19	2.98	4.48	1.49	0.30	1.49	3.28	2.09	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	63.45	4.53	4.53	4.53	4.53	4.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	107.40	2.30	5.37	1.53	2.30	2.30	0.00	2.30	2.30	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	91.29	0.74	3.71	7.42	0.74	2.23	1.48	0.74	0.74	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	122.71	1.27	5.50	7.62	2.54	1.27	3.39	1.69	2.12	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	112.53	1.41	4.92	6.33	0.70	0.00	1.41	4.22	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	86.86	2.80	0.93	5.60	0.00	4.67	1.87	0.93	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	104.60	2.06	3.61	6.70	1.03	3.61	2.58	2.58	4.64	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	78.50	4.76	3.57	2.38	1.19	2.38	1.19	0.00	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	98.17	2.49	2.94	5.88	3.85	1.36	1.36	2.26	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	73.00	1.74	4.65	4.36	2.04	2.04	1.16	1.16	2.33	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	82.38	1.80	3.60	4.05	1.35	0.90	0.45	0.00	1.35	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	117.33	2.57	5.83	7.86	4.34	2.71	2.30	2.57	2.44	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	102.19	2.05	6.68	8.73	3.59	3.08	1.03	2.57	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	83.63	3.18	6.00	2.82	0.71	2.12	0.35	1.06	0.71	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	67.96	0.67	4.00	2.00	2.67	0.00	1.33	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	97.80	2.04	4.58	3.06	3.06	3.57	1.02	1.53	1.02	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	84.31	2.93	3.47	3.47	1.07	1.60	1.33	0.53	1.07	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	92.02	2.27	3.59	4.35	2.65	2.08	1.13	1.13	1.89	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	105.53	1.23	3.07	6.14	1.23	1.23	1.23	4.29	1.23	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	116.61	1.63	4.08	4.08	0.82	1.63	1.63	0.00	0.82	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	85.80	1.67	2.50	3.12	2.50	2.08	1.25	1.67	1.67	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	87.72	2.24	4.76	2.52	1.40	2.52	2.24	1.96	0.84	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	108.19	5.15	5.15	2.06	5.15	2.06	3.09	1.03	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	77.80	2.32	3.48	6.68	0.87	1.45	2.03	0.29	1.16	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	78.02	1.20	4.19	4.78	1.49	0.90	1.79	0.90	2.09	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	76.90	2.21	2.21	5.53	1.66	1.11	0.55	1.11	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	109.23	2.47	2.83	4.60	2.12	3.53	1.41	2.47	2.83	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	92.93	1.48	3.69	2.95	1.48	1.84	0.37	1.84	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	89.80	0.00	3.45	3.45	0.00	5.76	0.00	2.30	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	101.31	1.15	6.52	3.84	1.54	3.45	1.54	1.15	4.22	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	98.51	0.57	3.96	7.36	3.96	3.40	1.13	2.26	2.83	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	84.51	3.28	4.10	4.92	0.82	3.28	2.46	1.64	3.28	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	106.64	3.16	4.07	2.71	2.71	2.26	1.81	0.90	3.62	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	101.26	1.44	2.15	5.03	0.72	1.44	1.44	2.87	3.59	4.31
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	94.86	1.49	2.99	7.47	2.24	4.48	1.49	2.24	2.24	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	119.28	2.97	4.83	9.66	3.34	2.97	1.11	1.86	4.46	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	84.86	0.00	3.88	3.45	2.15	3.02	0.86	1.29	2.15	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	99.33	0.00	5.99	5.14	1.71	4.28	2.57	2.57	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	95.62	1.67	3.33	6.33	1.33	1.67	2.33	1.00	3.66	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	105.58	4.83	5.43	7.84	1.21	3.02	0.60	2.41	1.81	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	91.72	0.71	2.13	7.82	3.55	0.71	1.42	0.71	2.13	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	95.90	3.09	5.50	7.56	2.75	2.75	1.03	0.69	1.72	3.44
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	119.16	1.61	9.12	5.37	0.00	1.61	2.15	0.00	3.22	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	98.98	2.02	3.37	6.06	2.69	2.69	1.35	0.67	1.35	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	99.64	0.37	3.70	8.15	2.22	4.07	0.74	0.37	4.44	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	54.66	0.00	5.81	3.49	3.49	1.16	0.00	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	95.20	3.17	2.12	6.35	1.06	4.23	2.12	3.17	3.17	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	103.64	2.40	3.20	5.20	3.20	1.60	2.00	0.40	5.20	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	95.95	1.45	10.18	5.81	2.91	4.36	2.18	1.45	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	121.11	3.83	4.60	3.07	3.07	4.60	1.53	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	119.37	1.97	3.45	2.47	8.39	0.99	4.44	0.49	1.97	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	79.98	0.94	0.94	6.59	0.94	2.82	2.82	0.00	5.65	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	107.60	4.53	3.02	4.53	2.01	2.51	1.01	2.01	3.52	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	110.85	1.35	4.51	3.60	2.25	1.80	1.35	0.45	1.35	4.51
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	86.06	1.72	3.44	10.33	0.00	1.72	0.00	1.72	0.00	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	125.59	4.90	2.67	4.01	2.67	2.67	2.23	0.00	2.23	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	106.75	2.74	5.87	3.91	3.13	3.13	3.91	1.17	2.74	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	98.96	3.30	1.98	6.60	2.64	2.64	1.32	1.32	1.98	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	107.94	4.15	4.67	3.63	0.52	3.11	1.04	1.04	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	121.21	2.19	6.56	6.56	1.75	4.81	3.94	1.75	3.50	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	78.27	3.35	3.35	6.15	2.80	1.12	1.12	1.12	3.35	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	110.41	2.65	3.09	3.53	1.77	1.77	2.21	0.88	2.21	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	102.60	3.09	4.24	5.40	2.70	1.93	3.09	0.77	1.16	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	95.70	1.52	4.56	2.53	2.03	0.00	1.52	1.01	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	101.41	2.40	4.81	5.29	1.44	2.88	2.40	0.48	0.48	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	104.55	3.18	5.57	5.17	2.78	0.80	1.99	1.19	2.39	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	77.17	0.61	3.65	3.65	0.61	1.22	1.22	1.82	1.22	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	58.79	0.69	4.15	1.38	2.08	1.38	0.69	0.00	2.08	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	101.46	4.94	3.80	3.80	2.28	1.90	2.66	3.42	2.28	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	86.24	1.03	6.71	4.13	0.52	3.61	2.07	1.55	1.03	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	86.47	0.60	4.84	3.02	0.00	3.63	1.81	0.60	2.42	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	100.77	3.17	5.39	5.39	2.54	3.17	2.85	1.58	2.54	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	91.69	3.20	9.06	5.33	5.33	2.67	2.13	1.07	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	94.82	2.30	4.60	2.87	0.57	3.45	2.30	2.87	1.15	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	105.42	1.54	2.57	5.14	2.06	4.11	2.57	0.51	3.09	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	99.03	2.83	6.37	4.24	0.00	1.41	2.12	0.00	1.41	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	101.01	3.40	4.54	2.27	1.70	3.97	0.00	1.13	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	98.18	2.91	4.99	4.99	3.33	2.50	1.66	0.42	1.66	2.91
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	97.10	1.57	3.13	7.83	2.35	1.57	2.35	0.78	3.92	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	91.03	0.42	3.76	7.52	0.84	3.76	0.84	1.25	0.84	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	106.40	1.86	3.25	6.04	2.79	2.79	4.18	0.93	3.25	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	82.96	2.68	2.01	4.01	1.34	2.01	4.68	0.00	1.34	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	99.44	2.14	3.74	2.67	0.53	2.67	2.14	2.67	2.14	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	109.51	1.21	3.64	4.85	4.45	2.02	1.21	2.42	2.42	3.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	77.09	0.00	1.84	1.84	4.59	1.84	5.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	96.91	1.78	2.67	2.67	0.89	5.33	2.67	3.56	3.56	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	113.97	2.85	2.28	3.99	2.85	0.57	1.71	0.57	3.99	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	102.00	1.53	5.37	6.14	6.14	3.83	2.30	3.07	2.30	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	83.17	2.19	4.38	4.92	2.19	3.28	1.09	1.09	0.55	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	106.02	3.12	1.34	5.35	0.45	3.56	1.78	0.45	2.23	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	103.46	1.56	3.12	5.46	2.86	2.08	2.86	1.56	0.78	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	96.15	1.99	7.29	1.99	1.33	0.66	2.65	1.99	2.65	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	108.09	2.08	4.16	8.31	12.47	4.16	2.08	0.00	4.16	2.08
Macrophage - monocyte derived, donor1	11232-116C8	39.66	1.37	1.14	5.47	0.68	0.00	0.46	1.37	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	40.37	1.28	1.10	3.67	1.47	0.00	0.73	0.73	0.00	0.37
Macrophage - monocyte derived, donor3	11389-118C3	52.69	2.36	1.97	4.06	0.39	0.26	0.66	0.39	0.52	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	20.18	1.59	1.06	1.59	0.00	1.06	0.53	1.59	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	39.14	3.64	1.43	2.85	1.11	1.58	1.11	1.43	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	41.00	3.06	1.25	2.50	0.69	2.50	0.83	0.97	0.42	0.42
Mammary Epithelial Cell, donor1	11273-116H4	50.22	2.09	2.09	1.69	1.59	0.70	1.69	0.50	0.70	0.00
Mammary Epithelial Cell, donor2	11350-117G9	42.56	3.76	2.32	1.16	0.87	0.58	0.87	1.16	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	66.35	8.23	2.99	1.00	1.50	0.75	1.50	0.75	1.50	0.25
Mast cell - stimulated, donor1	11487-119E2	17.63	0.68	0.68	1.36	0.68	0.68	1.36	4.07	2.03	0.68
Mast cell, donor1	11563-120D6	61.75	5.95	3.03	5.52	3.14	1.62	1.62	1.62	1.95	0.32
Mast cell, donor2	11565-120D8	80.83	2.97	2.08	7.13	3.57	0.59	2.67	2.38	3.27	0.59
Mast cell, donor3	11566-120D9	99.51	7.43	3.60	11.26	7.43	1.35	4.50	1.35	2.25	1.58
Mast cell, donor4	11567-120E1	78.01	3.90	3.37	6.91	3.55	0.71	1.77	3.01	1.95	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	86.39	1.22	3.99	4.44	3.11	1.33	2.44	0.78	1.44	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	61.87	0.00	2.92	4.67	4.09	0.00	1.75	1.75	4.09	0.00
Mast cell, expanded, donor5	11939-126A4	58.97	1.72	2.87	4.02	1.49	1.15	0.80	0.34	0.92	0.57
Mast cell, expanded, donor8	11941-126A6	84.69	1.34	3.51	4.02	1.84	1.00	0.84	0.50	3.35	0.84
Melanocyte - dark, donor1	11502-119F8	57.31	0.90	2.89	4.08	2.29	0.20	1.49	2.29	0.90	0.30
Melanocyte - dark, donor2	11582-120F7	40.84	0.35	3.11	2.42	2.08	1.04	1.38	0.35	1.38	0.00
Melanocyte - dark, donor3	11663-122F7	89.32	4.56	3.69	2.17	1.81	1.09	1.81	1.30	0.72	0.07
Melanocyte - light, donor1	11274-116H5	98.03	3.76	4.00	5.88	4.23	0.94	4.47	2.35	2.35	0.47
Melanocyte - light, donor2	11351-117H1	126.94	3.41	6.14	6.82	2.05	1.36	2.05	2.73	0.68	0.00
Melanocyte - light, donor3	11423-118G1	85.86	0.87	3.47	0.87	0.87	0.00	0.00	0.87	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	89.76	1.67	3.85	0.52	0.42	0.52	0.83	0.00	3.12	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	41.42	1.34	4.30	2.42	2.42	1.34	2.42	1.34	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	49.02	1.87	2.41	2.95	3.48	2.95	3.48	1.34	1.07	0.54
Meningeal Cells, donor1	11493-119E8	109.05	3.47	6.08	2.48	2.11	1.24	1.86	1.49	0.37	0.37
Meningeal Cells, donor2	11573-120E7	62.06	3.08	1.76	4.84	0.00	3.08	0.88	1.32	0.44	1.32
Meningeal Cells, donor3	11654-122E7	75.31	1.55	5.30	1.71	1.55	0.98	0.49	0.41	0.90	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	56.75	2.28	2.85	2.00	0.86	1.14	0.00	1.71	1.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	28.08	2.31	2.52	2.72	2.21	3.22	1.71	1.71	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	74.91	2.63	2.63	7.88	1.31	1.31	1.31	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	83.72	0.00	10.47	1.31	3.92	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	47.36	2.87	3.59	0.00	0.00	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	35.58	3.60	1.91	4.87	1.06	2.12	1.69	1.06	1.27	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	39.71	2.01	2.51	2.01	1.51	3.02	1.01	1.51	1.51	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	66.59	4.40	5.05	2.42	1.98	1.10	2.64	0.66	0.66	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	69.41	2.19	4.38	2.19	0.00	1.46	0.73	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	62.40	3.48	3.68	1.84	1.84	1.23	1.43	0.82	0.20	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	31.16	4.29	1.52	4.99	2.91	2.49	0.83	2.22	0.69	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	73.23	1.12	3.72	4.09	0.74	1.86	1.86	1.86	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	50.39	1.71	1.71	3.29	1.05	0.39	1.97	1.18	0.39	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	43.03	2.37	1.19	5.34	1.48	2.67	3.56	2.37	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	53.72	2.34	2.34	4.67	0.00	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	55.71	4.48	1.92	2.56	1.92	1.92	1.28	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	57.42	1.42	3.54	2.84	0.71	0.35	0.35	1.06	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	50.04	1.88	3.44	2.19	1.25	1.56	0.94	1.25	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	44.27	1.45	6.53	0.00	0.00	0.73	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	38.45	3.18	1.06	5.83	1.59	4.24	2.65	3.18	0.53	0.53
Mesothelial Cells, donor2	12156-128G5	15.01	1.50	0.50	4.00	1.00	3.00	0.50	2.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	26.52	1.88	1.66	2.53	2.38	1.66	1.08	1.37	0.87	0.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	20.25	1.35	0.00	2.70	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	38.67	1.97	1.48	5.91	2.46	0.49	0.99	0.74	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	30.62	1.18	1.18	3.83	1.47	0.29	2.36	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	38.43	1.55	0.93	4.96	0.93	0.62	0.93	1.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	30.70	0.41	1.45	4.98	2.07	0.21	2.49	2.07	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	38.54	2.25	0.50	6.26	1.50	0.50	2.75	1.25	0.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	28.39	2.33	1.86	5.59	1.86	0.47	1.86	1.40	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	33.53	1.02	1.02	5.69	1.02	0.20	1.02	2.24	0.81	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	32.86	1.58	1.19	1.58	3.96	0.40	1.58	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	44.25	2.65	1.77	9.73	0.88	0.00	2.65	1.77	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	33.43	1.14	1.14	7.60	5.32	0.00	3.04	1.90	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	0.00	0.00	2.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	37.14	1.06	1.70	6.15	1.06	0.00	0.00	1.49	0.42	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.94	0.00	1.84	2.76	1.84	0.00	1.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	29.51	0.89	0.89	3.87	0.89	0.60	0.89	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	1.68	0.00	3.35	0.00	0.00	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	31.86	1.00	1.51	4.77	1.25	0.25	1.51	2.01	1.51	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	26.62	1.19	0.95	3.33	1.19	0.24	1.43	1.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	15.48	1.11	1.11	0.55	1.66	0.55	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	37.99	0.92	0.92	5.76	0.92	0.69	0.92	0.69	0.23	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	22.51	0.63	0.21	4.42	2.10	0.00	1.89	0.84	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	30.98	1.02	0.41	3.87	1.83	0.41	2.04	0.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	34.33	0.86	1.07	3.22	1.29	0.43	1.93	0.86	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	21.34	0.44	0.89	1.78	1.33	0.00	3.11	0.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	33.95	0.88	1.31	3.07	1.10	0.22	2.85	1.10	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	15.21	0.51	0.51	1.52	0.51	0.00	1.52	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	23.20	0.00	1.66	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	26.09	0.54	1.09	3.26	1.90	0.27	1.09	0.82	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	20.88	0.29	1.47	4.12	2.65	0.00	1.47	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	13.08	0.00	0.00	1.09	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	41.33	0.00	0.00	3.36	0.48	0.00	1.92	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.01	1.20	1.60	4.40	0.40	0.00	0.80	0.80	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	48.06	1.50	3.50	4.51	0.50	0.50	0.50	0.50	1.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	38.10	0.00	2.19	2.19	0.44	0.88	0.00	2.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	20.97	0.00	1.10	3.31	1.10	0.00	1.10	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	12.17	0.64	1.28	1.28	0.64	0.00	1.28	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	41.40	0.50	1.98	2.48	0.25	0.25	0.50	0.74	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	22.96	0.00	0.00	0.00	1.39	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	48.55	0.34	0.34	2.05	0.68	0.00	0.68	0.00	1.03	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	15.32	1.31	0.88	0.00	0.88	0.00	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	21.66	0.36	0.00	0.36	0.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	42.08	0.00	2.24	1.96	0.84	0.00	0.84	0.56	1.12	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	18.70	0.42	0.83	0.00	1.25	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.07	1.17	0.00	0.58	0.00	0.00	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	36.50	1.21	2.41	1.21	0.00	0.00	1.21	0.60	0.30	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	30.89	0.42	0.42	2.50	0.83	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	7.22	0.00	0.00	0.00	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	17.55	0.00	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	30.16	0.57	0.00	1.14	0.57	0.00	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	25.01	1.11	0.83	1.66	1.38	0.28	0.69	0.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	40.17	1.55	1.81	0.78	0.78	0.00	0.26	0.26	0.26	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	22.31	0.86	0.43	0.86	0.43	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.16	0.64	1.91	1.27	0.64	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	23.22	1.87	0.27	1.33	0.27	0.00	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	36.82	1.80	1.80	2.69	1.50	0.90	1.50	1.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	22.46	1.55	0.99	1.13	0.71	0.28	0.71	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	33.44	1.27	0.96	0.64	1.27	0.00	0.32	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	31.84	1.33	1.11	1.11	0.66	0.44	0.88	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	16.31	0.76	0.76	1.52	0.76	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	31.82	1.14	0.85	1.70	0.57	0.00	0.28	0.28	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	38.35	2.46	0.98	3.69	0.49	0.00	2.21	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	16.94	1.30	1.30	1.30	1.30	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	32.34	2.65	1.76	2.06	0.59	0.29	0.29	0.88	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	39.79	1.15	0.86	1.73	1.73	0.58	3.46	2.02	0.58	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.13	1.24	1.24	2.47	1.24	0.00	1.24	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	40.80	1.49	2.08	3.57	0.30	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	0.00	0.00	7.53	0.00	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	0.00	1.78	5.35	0.00	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	47.64	1.97	1.31	3.61	0.66	0.33	1.64	1.97	0.99	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	54.70	1.05	0.00	2.10	0.00	0.00	1.05	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	42.30	0.40	0.59	3.95	0.99	0.40	0.99	0.59	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	33.53	1.86	1.86	5.59	0.93	0.93	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	53.70	0.75	1.50	2.25	1.88	0.75	0.75	2.25	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	37.55	0.53	2.40	3.46	0.53	0.53	1.07	0.27	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	31.78	1.58	0.57	4.41	0.79	0.00	1.24	0.68	0.00	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	50.83	0.74	0.00	5.16	0.74	0.74	0.74	1.47	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	46.17	1.83	1.83	5.13	0.73	0.00	2.20	1.47	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	57.56	1.56	0.00	3.11	0.00	1.56	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.02	0.00	0.53	1.07	0.00	0.00	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	3.86	0.00	7.73	0.00	3.86	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	54.54	2.02	2.02	5.05	2.02	0.00	0.00	0.00	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	18.13	0.00	1.26	2.95	0.00	0.00	0.84	0.00	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	0.00	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	0.00	0.00	0.00	0.00	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	0.00	0.00	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	11.42	0.00	11.42	5.71	0.00	0.00	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	0.00	0.00	6.52	3.26	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	57.03	0.00	0.00	4.75	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	39.86	3.02	1.72	4.09	1.08	1.72	1.29	3.02	0.22	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	26.65	2.61	1.57	2.61	2.09	1.57	0.52	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	24.03	0.67	2.00	1.33	0.00	3.34	0.67	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	17.11	0.83	1.67	1.25	0.83	1.25	0.00	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	22.06	4.75	1.14	2.28	2.66	2.09	1.33	0.95	0.95	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	28.73	0.00	0.00	1.60	0.00	6.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	22.44	0.00	0.00	2.04	0.00	2.04	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	25.73	1.84	3.68	9.19	3.68	0.00	1.84	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	11.72	0.00	1.67	4.60	0.42	2.09	1.26	0.42	2.09	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	17.67	1.63	0.46	3.95	2.56	1.16	0.93	2.56	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	19.73	0.81	0.81	2.97	1.08	1.89	0.54	0.81	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	25.65	1.89	1.05	3.15	1.05	2.10	1.05	1.26	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	22.27	11.13	0.00	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	20.35	0.00	0.99	3.97	0.50	3.97	0.00	0.99	0.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.24	1.35	1.35	3.52	1.89	2.98	2.17	0.81	0.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	17.00	0.68	0.91	3.17	1.13	1.36	0.68	1.59	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.08	0.33	1.47	3.10	0.49	2.45	0.65	0.98	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	24.60	1.64	1.28	4.56	2.00	2.55	0.73	0.36	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	15.38	0.53	0.00	4.77	0.53	0.53	1.59	0.00	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	8.40	0.60	0.60	3.00	0.00	1.20	0.00	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.07	6.56	1.31	6.89	2.30	6.56	1.31	1.97	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.06	0.33	1.63	5.04	1.46	2.11	0.65	1.30	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.05	1.41	1.06	3.00	0.71	1.59	0.35	1.41	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.06	0.00	0.00	2.11	0.00	2.11	0.70	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	16.55	0.92	0.46	2.76	1.38	2.76	0.00	1.38	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.96	1.93	1.29	2.89	0.96	4.50	0.00	1.29	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.83	4.48	0.69	3.45	4.14	1.38	2.41	3.10	0.69	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	37.93	17.70	2.53	10.11	2.53	5.06	7.59	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.61	1.34	1.34	4.01	1.78	1.78	0.22	1.11	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.70	0.42	1.27	2.54	0.42	2.12	0.85	2.12	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	13.05	0.95	0.47	2.85	0.95	2.85	0.71	0.95	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	20.60	0.86	0.86	3.00	0.86	1.72	1.72	0.00	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	36.11	0.00	0.00	18.06	0.00	9.03	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	13.00	0.00	1.33	2.67	1.67	1.67	0.67	0.67	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	25.70	1.80	0.90	2.71	2.71	3.16	0.45	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	16.27	0.00	1.19	1.98	0.00	1.98	0.79	1.19	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	20.43	0.00	0.93	1.86	0.93	0.93	0.93	0.00	0.93	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.43	1.14	1.51	3.41	0.76	7.19	0.76	0.76	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.71	0.00	0.65	1.96	0.98	2.28	0.00	0.65	0.65	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.59	0.87	0.44	2.61	0.44	1.31	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	24.42	0.45	0.45	4.98	0.90	1.36	0.90	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	18.52	0.00	0.88	3.53	0.88	4.41	2.65	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	22.60	0.00	3.32	3.99	0.66	1.33	0.00	0.66	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	19.84	0.99	1.49	4.96	0.00	3.47	0.00	1.49	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	15.70	0.77	0.38	1.15	1.91	2.68	1.53	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	30.24	2.12	1.51	1.51	2.72	1.51	2.42	0.30	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	25.42	1.77	1.11	3.76	1.55	4.42	0.66	1.99	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	0.00	0.00	1.36	0.00	1.36	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	5.11	5.11	10.22	5.11	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	23.17	1.22	1.83	4.88	1.83	3.66	0.61	0.61	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	12.59	0.31	1.26	0.94	0.94	0.94	0.94	0.94	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.04	1.21	0.91	1.51	0.91	1.21	0.30	0.30	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	20.57	0.00	1.58	4.75	1.58	3.96	1.58	1.58	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	28.34	3.40	1.13	6.80	3.40	1.13	2.27	1.13	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	10.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.06
Myoblast, donor1	11241-116D8	26.09	1.49	0.99	3.11	1.12	0.99	1.24	1.12	0.25	0.37
Myoblast, donor2	11322-117D8	47.56	2.11	4.22	3.64	2.49	2.69	1.73	2.30	0.96	0.58
Myoblast, donor3	11398-118D3	35.82	5.38	2.02	3.36	0.50	1.01	1.18	1.85	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	65.82	1.31	2.77	0.15	1.46	0.00	0.73	0.00	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	74.73	1.23	4.00	0.31	3.08	0.31	1.23	0.00	0.62	0.31
Natural Killer Cells, donor2	11311-117C6	67.85	2.41	4.22	2.11	1.51	1.21	1.21	0.90	1.21	1.21
Natural Killer Cells, donor3	11387-118C1	77.12	1.66	4.79	1.66	2.39	0.74	1.47	0.92	0.92	0.00
Neural stem cells, donor1	11275-116H6	75.49	5.08	3.27	7.62	13.07	7.62	8.35	4.72	2.54	1.45
Neural stem cells, donor2	11352-117H2	77.03	11.55	9.63	0.00	1.93	9.63	11.55	3.85	0.00	0.00
Neurons, donor1	11494-119E9	62.58	3.41	2.28	6.83	2.28	6.83	3.41	0.00	3.41	0.00
Neurons, donor2	11574-120E8	77.72	12.33	4.40	4.40	4.62	11.89	3.74	3.08	3.52	0.44
Neurons, donor3	11655-122E8	52.62	2.47	5.76	4.93	1.64	6.58	3.29	0.00	2.47	0.00
Neutrophils, donor1	11233-116C9	65.89	2.78	1.86	6.50	9.28	0.00	9.28	0.93	1.86	0.00
Neutrophils, donor2	11314-117C9	55.08	2.90	0.00	2.90	8.70	0.00	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	62.31	1.22	0.00	3.67	11.61	0.61	4.89	1.22	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	40.01	5.94	3.56	6.41	3.21	4.99	3.32	2.37	1.07	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	26.37	2.93	2.28	5.54	2.28	1.95	1.63	1.30	1.63	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	25.27	4.61	1.20	1.40	1.80	2.21	0.80	1.20	0.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	22.85	1.10	2.34	3.44	0.14	1.24	0.28	0.69	0.69	0.28
Olfactory epithelial cells, donor2	11934-125I8	28.37	0.87	2.61	1.74	0.87	1.30	0.72	0.87	1.01	0.14
Olfactory epithelial cells, donor3	11935-125I9	27.13	1.02	1.36	0.57	0.68	2.72	0.68	0.23	1.14	0.34
Olfactory epithelial cells, donor4	11936-126A1	33.21	1.36	1.56	2.82	1.36	2.14	0.58	0.68	0.19	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	58.98	7.22	1.20	9.03	2.41	1.81	1.20	3.61	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	53.60	2.55	2.98	7.87	1.28	2.77	1.70	2.98	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	33.15	2.29	3.43	3.43	2.29	2.29	3.43	1.14	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	32.90	0.62	1.86	1.86	0.00	0.62	0.00	0.62	1.24	1.24
Osteoblast, donor1	11277-116H8	91.07	6.64	6.64	2.15	4.50	4.69	3.52	1.37	0.78	0.20
Osteoblast, donor2	11354-117H4	61.80	4.92	1.40	2.81	0.00	3.51	0.70	1.40	1.40	0.70
Osteoblast, donor3	11426-118G4	56.52	6.58	2.13	3.38	1.07	1.42	1.24	1.24	0.18	0.36
Pancreatic stromal cells, donor1	11249-116E7	47.09	2.95	3.45	4.30	2.70	2.53	2.44	1.52	1.35	0.76
Pericytes, donor1	11491-119E6	72.55	12.57	4.78	7.68	4.12	5.79	3.34	4.23	1.11	0.22
Pericytes, donor2	11571-120E5	65.19	9.28	4.53	6.34	2.72	4.53	2.72	2.72	1.13	0.45
Pericytes, donor3	11652-122E5	56.15	3.05	2.44	2.24	1.63	2.03	0.81	1.02	0.81	0.81
Perineurial Cells, donor1	11499-119F5	56.85	4.86	2.26	2.26	1.47	2.03	0.57	0.79	0.79	0.45
Perineurial Cells, donor2	11579-120F4	58.43	3.40	3.77	2.58	2.02	1.01	1.56	1.56	0.74	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	96.26	0.32	4.14	1.91	0.64	0.32	2.23	0.00	1.59	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	63.17	1.71	2.94	0.98	1.71	0.00	1.22	0.49	2.20	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	74.54	2.59	4.40	1.16	1.16	0.52	1.55	0.52	0.78	0.65
Placental Epithelial Cells, donor1	11278-116H9	88.25	5.02	3.59	2.63	5.74	0.96	4.30	1.91	1.67	0.48
Placental Epithelial Cells, donor2	11355-117H5	66.53	1.11	2.22	1.11	4.44	6.65	2.22	0.00	1.11	2.22
Placental Epithelial Cells, donor3	11427-118G5	65.18	2.55	2.55	2.36	2.16	3.14	0.59	1.77	1.18	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	17.40	0.00	0.95	0.95	0.00	0.32	0.00	0.00	0.95	0.32
Preadipocyte - breast, donor1	11467-119B9	24.76	0.56	1.88	2.63	0.94	1.50	0.75	0.94	0.56	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	74.14	4.70	3.65	0.91	1.31	1.57	1.44	0.26	1.04	0.00
Preadipocyte - breast, donor2	11328-117E5	42.33	2.03	2.03	0.45	1.13	0.45	0.45	0.68	0.90	0.23
Preadipocyte - omental, donor1	11468-119C1	29.52	1.70	2.24	2.45	0.96	1.70	1.17	0.85	0.75	0.11
Preadipocyte - omental, donor2	11329-117E6	35.79	1.31	1.75	3.06	0.87	0.44	1.75	0.44	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	45.70	1.15	2.15	1.86	0.86	2.58	0.72	0.57	1.00	0.43
Preadipocyte - perirenal, donor1	11469-119C2	36.42	0.98	0.00	0.00	0.98	0.00	0.00	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	79.54	6.45	5.53	3.38	3.99	5.84	2.76	2.15	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	49.40	3.19	4.78	2.48	2.66	1.59	1.24	0.71	3.01	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	44.96	3.58	3.92	3.07	1.53	3.41	1.70	0.34	2.21	1.02
Preadipocyte - visceral, donor1	11280-116I2	46.48	2.51	4.47	1.96	3.35	2.61	2.05	1.49	0.47	0.09
Preadipocyte - visceral, donor2	11357-117H7	34.51	5.06	1.84	5.06	3.22	4.60	0.92	0.92	3.22	0.46
Preadipocyte - visceral, donor3	11429-118G7	34.17	1.88	2.19	1.25	1.99	1.67	2.30	1.04	1.46	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	83.72	1.66	2.56	4.68	3.62	1.06	2.87	4.07	3.92	1.36
Prostate Epithelial Cells, donor2	11331-117E8	31.42	1.62	1.08	5.42	1.35	1.90	1.35	2.57	2.17	0.54
Prostate Epithelial Cells, donor3	11404-118D9	44.64	1.41	0.61	1.41	2.20	0.12	2.14	1.04	2.45	0.80
Prostate Stromal Cells, donor1	11254-116F3	38.38	0.91	3.99	0.91	1.48	0.91	1.14	0.46	0.80	0.11
Prostate Stromal Cells, donor2	11332-117E9	47.69	2.33	2.69	1.08	0.90	0.72	0.90	0.18	1.43	0.90
Prostate Stromal Cells, donor3	11405-118E1	33.99	4.48	2.19	4.59	0.83	1.88	1.46	1.25	2.50	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	109.49	8.39	5.11	5.84	0.36	1.82	1.09	3.28	1.82	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	64.81	2.77	3.47	4.92	0.62	2.29	1.18	3.05	1.11	0.14
Renal Epithelial Cells, donor1	11517-119H5	131.88	3.55	7.61	1.52	2.03	0.51	1.52	1.52	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	112.39	1.42	5.69	0.00	0.71	3.56	0.71	2.13	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	58.86	2.01	3.07	6.03	3.07	2.96	1.59	2.65	1.59	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	90.55	4.09	5.45	3.40	1.36	2.04	4.09	2.04	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	65.23	1.48	3.50	3.64	1.35	1.08	0.54	1.75	0.67	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	51.28	2.22	3.33	1.33	1.33	2.00	0.22	0.44	0.67	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	84.51	1.33	1.33	1.33	2.66	0.67	3.99	0.67	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	80.99	6.82	3.30	2.86	3.08	3.74	2.20	0.66	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	79.00	2.51	5.64	3.76	0.63	1.88	0.00	0.63	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	74.62	3.88	4.44	3.33	4.44	4.16	2.50	1.94	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	110.05	4.83	7.25	0.81	1.07	1.34	0.00	1.34	1.88	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	88.13	4.22	2.11	0.84	0.42	0.42	1.27	0.42	1.27	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	91.41	5.01	4.63	3.28	1.35	1.93	0.39	2.31	1.16	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	78.82	7.26	2.59	1.04	3.63	2.85	2.07	1.56	1.56	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	77.03	5.68	5.40	3.98	1.71	3.13	1.71	4.26	0.28	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	88.50	1.03	3.09	1.03	2.06	1.03	2.06	1.03	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	47.17	0.50	5.27	2.26	3.76	2.26	2.01	1.25	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	76.44	3.74	4.54	2.00	1.87	0.13	2.00	1.07	1.74	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	53.60	0.89	0.89	8.04	0.00	1.79	0.00	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	45.13	0.00	2.20	18.16	3.85	3.85	3.85	6.05	1.65	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	31.90	0.58	0.00	6.96	0.58	3.48	2.32	1.74	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	61.89	2.86	1.82	3.77	0.78	2.47	0.78	1.82	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	78.75	1.69	2.18	4.47	0.79	2.38	0.79	1.99	1.19	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	75.18	1.67	1.90	5.02	0.89	1.78	1.12	2.12	0.78	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	100.35	6.45	3.47	7.69	1.24	3.23	1.49	3.35	1.24	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	82.16	2.68	3.03	3.03	1.40	2.68	0.93	1.63	2.56	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	76.74	0.69	5.08	5.08	1.85	2.08	0.69	2.31	1.39	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	65.17	1.78	2.74	3.29	0.41	1.37	0.14	1.37	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	70.95	2.12	2.42	4.08	0.45	2.57	0.30	1.51	1.06	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	74.54	2.69	3.23	5.38	1.08	2.33	0.54	2.33	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	77.04	2.73	2.73	4.30	0.86	2.58	0.29	1.58	0.72	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	83.06	1.18	3.11	4.08	1.40	2.58	1.29	2.25	2.58	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	79.44	3.10	3.54	5.31	1.11	2.66	1.55	1.33	2.88	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	62.32	1.34	2.29	4.40	0.96	2.87	0.38	1.34	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	73.79	1.40	2.89	4.29	0.56	2.42	0.84	1.58	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	72.16	0.19	1.88	9.58	1.50	2.25	0.94	1.69	0.56	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	57.86	2.52	1.19	2.65	0.53	2.12	0.27	0.93	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	75.24	2.43	3.02	3.60	0.78	1.75	0.49	0.78	1.75	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	73.71	1.91	2.86	4.01	0.57	2.10	0.76	2.29	1.15	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	65.68	2.56	3.31	2.24	0.32	1.92	0.75	0.96	0.53	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	67.55	1.12	4.77	2.80	0.28	2.52	1.40	1.12	0.56	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	76.73	1.03	2.73	5.30	1.37	2.05	0.34	1.71	1.20	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	65.09	3.46	3.83	2.19	1.28	1.46	0.55	1.09	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	88.66	1.47	2.58	4.91	0.86	2.70	0.74	1.35	1.84	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	88.38	1.75	3.90	3.36	0.94	2.42	1.34	1.88	0.81	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	81.85	2.36	3.54	6.37	0.47	2.12	0.47	0.71	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	77.18	0.99	3.17	3.57	0.79	1.59	1.19	2.98	1.98	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	86.76	2.81	2.81	4.91	0.47	3.74	0.70	2.10	1.17	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	77.14	1.87	3.11	3.11	0.21	2.49	0.21	1.66	1.04	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	77.64	0.44	2.43	6.42	1.11	2.21	0.44	0.66	1.33	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	82.51	1.88	2.09	5.43	1.25	1.88	1.04	1.67	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	80.48	2.83	4.44	3.90	0.94	2.83	0.54	1.88	1.08	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	61.31	2.21	2.55	2.04	1.36	1.53	0.51	1.02	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	72.88	1.93	1.93	3.28	0.39	1.93	0.77	1.16	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	83.39	1.72	4.13	3.27	0.52	2.75	0.69	1.03	0.69	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	71.74	1.51	2.88	4.12	0.69	1.65	0.14	1.65	0.82	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	79.62	1.15	2.96	2.46	0.66	1.64	1.15	2.13	0.16	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	58.63	2.39	0.85	4.60	0.17	2.39	1.02	1.36	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	91.29	2.22	3.26	6.51	1.04	3.40	1.63	2.52	1.63	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	61.04	1.60	2.93	4.80	0.27	3.47	0.53	1.33	0.27	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	55.31	3.59	3.18	4.42	0.41	1.11	0.69	3.04	0.69	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	78.81	1.43	3.10	3.33	1.19	3.57	1.43	2.62	1.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	67.31	1.81	2.22	7.26	1.41	2.22	1.01	1.01	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	71.29	2.26	3.11	6.97	0.94	2.54	0.66	1.79	1.22	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	86.99	2.10	2.10	6.99	2.10	1.75	0.70	2.45	1.40	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	64.37	1.21	4.23	4.23	1.81	1.51	0.91	0.91	0.91	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	87.38	3.06	4.16	6.12	0.61	2.94	1.22	2.20	2.33	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	85.58	2.18	2.62	10.77	2.91	1.02	2.62	4.22	0.44	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	74.84	1.83	0.61	10.34	0.61	1.83	1.22	2.43	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	76.86	0.90	3.92	4.22	0.60	2.11	0.30	2.11	1.81	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	98.84	1.13	3.39	9.50	2.26	0.68	2.94	3.62	6.11	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	81.47	1.20	3.00	12.88	1.20	3.00	2.40	5.39	1.20	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	75.45	2.24	2.83	4.60	1.18	1.53	1.89	3.19	2.72	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	82.39	2.77	3.63	8.32	2.35	2.99	1.92	3.63	2.13	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	61.90	0.60	1.80	13.22	1.20	4.21	2.40	3.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	88.58	5.08	5.27	2.63	0.94	0.75	1.13	0.19	1.13	0.56
Schwann Cells, donor2	11578-120F3	54.44	0.00	0.00	3.40	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	40.31	1.53	2.19	1.10	1.10	1.75	1.10	0.44	1.53	0.00
Sebocyte, donor1	11220-116B5	65.73	5.48	3.83	3.83	3.29	2.74	1.10	6.03	2.19	0.55
Sebocyte, donor2	11301-117B5	36.76	3.68	1.38	4.60	0.92	1.38	1.38	0.46	1.84	0.00
Sebocyte, donor3	11378-118B1	61.42	3.09	1.86	8.45	3.30	1.03	2.06	3.09	1.03	0.82
Sertoli Cells, donor1	11255-116F4	34.79	1.66	6.63	4.97	1.66	1.66	1.66	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	19.77	2.82	2.82	2.82	0.00	5.65	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	56.48	4.05	2.82	3.87	1.06	3.26	1.76	1.41	2.02	0.53
Skeletal Muscle Cells, donor2	11358-117H8	70.84	3.61	4.34	13.73	1.45	1.45	1.45	0.72	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	122.90	6.69	9.20	6.69	3.34	8.36	3.34	0.00	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	47.44	2.36	4.71	2.04	0.79	1.26	1.73	0.31	0.63	0.16
Skeletal Muscle Cells, donor5	11455-119A6	41.17	3.27	3.12	1.49	1.64	1.64	1.04	0.15	0.15	0.45
Skeletal Muscle Cells, donor6	11459-119B1	60.18	2.92	2.31	0.77	0.77	0.62	0.77	0.31	0.62	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	48.26	3.02	3.65	4.41	2.52	2.77	0.76	1.26	1.13	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	44.38	4.28	3.14	2.14	0.71	2.43	1.00	0.57	1.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	66.77	2.68	3.97	1.49	2.28	0.89	1.19	0.79	1.29	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	58.47	2.78	4.30	7.75	2.02	6.15	1.77	2.19	1.35	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	78.89	5.07	2.90	4.34	0.72	1.45	1.45	0.72	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	48.43	4.68	1.93	2.06	3.99	1.51	2.61	1.79	0.83	1.10
Skin - palm, donor1	10286-104F7	32.23	2.69	2.69	2.69	0.00	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	34.74	0.72	2.02	0.58	0.58	1.15	0.29	0.58	0.43	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	47.44	0.82	2.45	1.64	0.00	3.27	1.64	0.82	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	31.81	0.26	1.56	0.39	0.26	0.52	0.13	0.26	1.17	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	32.53	0.70	1.25	0.56	1.67	0.56	0.83	0.83	1.25	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	25.60	1.69	1.13	0.42	0.42	0.42	0.56	0.14	0.42	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	72.31	4.86	3.81	1.48	3.38	1.27	1.48	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	37.70	1.42	1.50	0.60	0.45	0.30	0.82	0.15	0.82	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	31.17	3.09	1.23	3.70	1.54	2.16	0.62	1.85	0.62	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	54.47	7.78	1.33	1.56	2.45	2.22	0.67	0.44	2.00	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	56.43	4.70	3.53	4.70	4.11	2.94	1.18	1.18	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	81.77	3.09	1.99	1.33	2.87	2.43	1.55	1.10	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	59.46	6.30	1.58	5.51	0.79	1.18	1.58	1.58	1.18	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	61.03	4.64	3.86	6.18	3.86	3.86	0.77	2.32	2.32	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	23.02	1.00	1.00	3.00	0.00	1.00	0.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	68.00	2.79	3.86	3.73	3.99	2.00	2.26	2.13	1.73	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	42.11	1.11	3.10	1.33	3.99	1.11	1.77	0.89	1.55	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	27.91	3.07	1.41	0.77	1.02	1.15	0.51	1.28	0.13	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	34.51	2.93	2.28	0.65	1.30	1.95	0.33	2.28	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	29.83	3.84	0.59	3.54	1.77	3.54	1.48	0.89	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	24.49	1.71	1.00	1.99	1.14	1.42	0.57	1.00	0.57	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	61.98	2.93	3.42	1.30	2.60	1.79	1.14	0.65	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	26.18	3.35	2.13	2.74	2.13	0.91	1.52	0.61	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	79.56	8.33	4.80	6.06	5.05	3.79	4.55	1.77	0.00	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	85.69	0.00	0.00	0.00	0.00	6.12	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	57.70	2.86	2.38	2.38	1.43	1.91	0.48	0.95	2.38	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	29.49	2.80	1.62	2.21	0.44	1.47	0.74	1.03	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	34.01	2.37	1.51	3.44	1.51	3.66	0.43	1.72	1.29	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	43.35	3.46	2.41	2.94	2.41	1.68	1.15	1.36	0.21	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	53.98	2.63	2.63	4.02	1.39	4.18	1.70	1.86	0.46	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	35.57	4.31	2.16	0.00	4.31	5.39	2.16	2.16	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	42.74	2.69	2.39	2.69	1.79	1.79	0.30	1.49	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	64.87	6.49	3.76	2.39	2.39	3.07	1.02	0.34	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	40.84	2.59	2.36	4.87	2.43	2.91	1.33	0.71	0.94	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	41.36	3.12	2.31	5.94	3.22	6.54	1.81	3.72	4.53	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	37.09	0.91	2.73	0.91	2.96	0.91	1.82	0.68	2.73	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	67.63	3.62	2.42	4.23	1.21	4.23	1.21	2.42	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	64.38	2.91	3.71	1.06	0.53	1.06	0.79	0.00	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	41.81	2.00	3.06	1.86	1.07	1.33	1.33	0.53	0.67	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	33.31	2.38	1.75	3.01	1.38	2.38	1.13	0.75	2.00	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	23.84	2.79	2.28	6.60	1.27	0.76	1.01	2.03	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	58.65	4.07	4.07	3.02	3.62	3.92	1.51	1.36	0.45	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	52.51	5.25	3.00	5.25	0.75	5.25	1.50	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	175.74	12.92	1.29	0.00	0.00	0.00	0.00	7.75	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	74.88	4.65	2.79	1.86	1.40	4.65	2.33	1.86	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	49.48	5.05	4.54	4.54	0.50	2.52	1.01	2.52	2.52	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	35.41	1.57	2.19	5.01	1.88	2.19	0.63	1.88	0.94	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	28.91	2.36	2.36	4.13	1.47	2.95	2.36	1.77	1.47	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	43.90	4.00	3.08	1.75	1.17	1.83	1.17	0.50	0.17	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	25.69	2.80	1.40	2.80	1.40	3.27	0.47	0.47	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	55.55	4.32	4.03	5.18	2.16	2.16	3.31	1.73	0.43	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	68.84	2.80	4.08	3.31	1.78	1.27	1.02	0.76	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	65.62	3.38	4.14	3.20	1.50	2.26	1.32	0.38	0.94	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	48.91	3.49	4.05	1.96	1.82	1.26	0.56	0.70	0.70	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	34.60	2.35	2.43	0.75	1.34	1.51	0.84	1.01	0.25	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	52.86	2.38	1.43	1.43	0.48	0.48	0.48	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	53.09	3.18	1.22	4.89	1.71	0.98	3.43	3.18	0.49	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	35.13	2.87	1.33	0.88	1.77	1.10	0.88	0.00	0.66	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	55.88	6.14	2.63	2.63	1.46	1.17	2.05	0.59	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	17.69	1.55	1.55	5.83	1.94	2.33	1.36	0.97	0.19	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	24.07	0.26	1.32	2.12	0.79	1.85	0.79	1.59	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	11.53	1.12	1.12	12.27	0.37	3.72	1.12	2.60	2.23	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	28.03	1.44	1.44	5.75	1.80	0.36	1.08	1.08	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.13	0.57	1.99	3.69	1.70	1.42	1.70	1.70	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	38.60	0.79	0.79	0.79	1.18	1.97	0.39	1.18	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	17.27	0.51	1.27	3.81	1.52	1.27	0.76	1.02	0.51	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	17.57	0.00	2.00	5.19	0.80	0.80	0.00	0.40	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	15.05	1.25	1.25	4.18	1.25	0.42	0.84	1.25	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	28.88	0.92	3.21	1.83	0.00	0.46	0.92	0.46	1.38	0.46
Synoviocyte, donor1	11291-117A4	36.53	0.84	1.51	2.52	2.02	2.36	0.67	0.34	1.68	1.01
Synoviocyte, donor2	11368-117I9	32.69	1.34	2.18	2.85	0.50	1.17	0.84	0.50	1.34	0.67
Synoviocyte, donor3	11440-118H9	28.60	3.80	0.89	3.13	0.45	1.79	0.22	0.89	2.01	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	114.70	4.65	8.58	3.93	1.43	1.07	1.43	1.43	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	91.17	1.98	7.93	5.95	0.00	3.96	0.00	0.00	3.96	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	80.12	3.94	3.94	6.02	1.85	2.78	0.93	0.93	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	40.43	2.58	1.15	1.29	0.50	0.93	0.29	0.57	0.79	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	61.46	3.48	2.71	1.55	0.39	0.77	3.48	1.16	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	68.15	1.15	2.29	1.15	0.57	1.72	0.57	0.57	1.72	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	79.23	2.71	4.55	1.11	2.46	0.12	2.09	0.62	3.20	0.25
Urethra, donor2	10319-105A4	35.97	5.40	1.80	1.80	1.80	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	49.94	4.78	1.59	2.13	0.53	1.06	0.80	1.33	0.27	0.27
Urothelial Cells, donor2	11600-120H7	41.66	2.80	0.40	2.00	1.60	0.40	0.40	0.00	0.80	0.00
Urothelial Cells, donor3	11681-122H7	47.90	2.98	1.15	1.60	0.46	0.46	0.46	0.69	0.46	0.69
Urothelial cells, donor0	11216-116B1	57.51	4.68	1.56	2.01	1.78	2.01	1.11	0.22	1.34	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	148.59	133.47	5.34	1.78	8.01	4.45	3.56	0.00	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	181.56	135.81	8.58	1.43	10.01	7.15	7.15	0.00	1.43	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	96.52	59.55	4.11	2.05	8.21	0.68	4.11	0.68	0.68	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	101.92	35.12	2.75	3.44	6.54	2.41	2.07	1.03	0.34	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	103.42	40.67	3.49	2.91	5.23	0.58	4.07	1.16	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	154.10	99.96	8.33	1.04	10.41	2.08	4.16	0.00	2.08	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	149.60	114.72	7.34	3.67	7.34	2.75	4.59	0.00	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	101.33	56.60	2.74	2.74	7.30	0.00	0.91	0.00	6.39	4.56
Wilms' tumor cell line:G-401	10809-111A8	64.89	3.08	3.95	2.59	1.73	2.47	1.97	1.23	1.36	0.25
Wilms' tumor cell line:HFWT	10597-108E3	27.28	1.76	0.00	0.00	2.64	2.64	1.76	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	67.87	6.14	5.59	1.12	1.40	0.56	1.12	0.00	0.56	0.28
achilles tendon, donor2	10292-104G4	49.60	0.00	0.00	2.07	4.13	0.00	2.07	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	69.86	1.78	2.80	0.51	0.51	0.51	1.02	0.00	0.25	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	130.48	1.63	6.73	0.00	1.16	0.46	0.46	0.23	0.93	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	154.68	4.75	3.21	1.66	1.31	1.19	1.07	1.07	1.78	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	80.55	4.35	5.17	0.82	2.99	7.35	1.63	1.63	1.36	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	176.52	1.41	6.46	0.84	1.12	1.69	0.84	0.00	2.25	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	58.16	1.48	2.54	1.69	1.48	1.69	1.69	0.42	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	125.22	1.63	6.26	9.53	1.63	2.99	2.99	4.63	1.09	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	77.55	2.20	1.32	5.73	1.76	3.08	1.76	0.88	0.44	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	70.65	1.23	2.86	4.49	2.45	0.41	1.23	0.41	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	103.29	1.55	5.05	0.78	1.55	0.78	0.39	0.78	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	101.02	1.66	9.02	0.37	0.37	0.18	0.74	0.00	1.66	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	120.92	0.00	7.80	3.90	0.00	0.00	0.00	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	88.54	2.56	5.58	2.09	3.02	3.49	2.32	0.70	1.63	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	180.45	1.29	6.47	1.81	1.29	1.55	1.81	0.52	2.33	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	108.42	1.75	5.26	1.17	0.29	0.29	0.58	0.00	1.17	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	65.07	0.46	2.32	0.00	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	87.60	0.41	2.47	0.00	0.82	0.00	0.41	0.00	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	158.69	0.61	5.53	1.53	0.31	0.31	0.92	0.00	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	196.29	2.99	6.40	3.84	1.28	0.00	0.85	0.85	2.56	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	170.75	1.82	4.85	2.43	2.12	1.52	0.61	0.30	1.52	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	188.47	2.41	6.26	3.13	1.44	0.48	1.68	0.72	2.65	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	106.02	0.67	8.24	0.89	0.45	0.22	0.45	0.22	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	72.71	1.67	5.67	3.34	1.67	1.67	2.67	2.00	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	44.60	1.86	1.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	113.37	0.75	5.65	2.26	2.26	0.38	2.26	0.75	2.26	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	64.55	2.18	3.93	1.74	1.31	0.87	0.87	0.44	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	37.49	3.75	7.50	5.62	3.75	0.00	1.87	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	30.38	1.88	0.94	0.94	0.71	1.41	0.24	0.94	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	63.91	1.55	2.79	1.09	1.09	0.47	0.93	0.16	1.86	0.47
adipose, donor1	10184-103D4	58.64	17.01	0.59	9.97	11.73	4.69	7.62	7.04	1.76	0.00
adipose, donor2	10185-103D5	42.98	3.24	1.62	7.70	6.49	4.87	2.43	4.87	3.24	0.81
adipose, donor3	10186-103D6	48.20	7.08	2.45	6.53	3.27	3.27	2.72	4.63	1.91	0.00
adipose, donor4	10187-103D7	54.61	12.13	2.60	4.33	8.67	1.73	0.87	3.47	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	71.81	6.15	2.21	6.63	0.95	8.36	1.10	1.89	0.16	0.32
adrenal gland, adult, pool1	10081-102A9	54.57	0.00	3.64	3.64	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	92.18	2.27	5.07	0.67	0.93	0.40	0.27	0.13	1.20	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	94.33	2.50	2.86	2.14	1.79	5.36	0.36	0.71	0.00	1.07
amniotic membrane cells, donor1	12235-129G3	51.01	4.41	0.93	1.39	0.93	0.46	0.70	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	62.55	5.07	2.03	1.69	1.01	1.01	0.00	0.34	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	53.91	7.95	0.59	1.77	1.47	0.29	0.59	0.88	0.59	0.00
amygdala - adult, donor10196	10167-103B5	42.69	4.74	2.37	1.19	0.00	4.74	1.19	0.00	1.19	1.19
amygdala, adult, donor10252	10151-102I7	58.60	8.92	3.65	1.22	1.62	4.06	0.41	0.20	0.81	1.01
amygdala, newborn, donor10223	10360-105E9	33.89	0.65	1.94	0.97	0.32	5.81	0.65	0.97	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	91.68	3.44	4.97	4.71	0.51	2.42	0.25	1.66	1.78	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	76.34	1.32	5.07	0.44	0.00	0.00	0.22	0.00	1.10	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	59.46	6.35	1.34	5.01	2.34	7.68	1.34	0.67	0.33	0.00
aorta, adult, pool1	10052-101G7	48.64	1.96	2.75	0.98	1.37	0.59	0.39	0.00	0.20	0.59
appendix, adult	10189-103D9	81.89	2.33	6.21	0.39	1.55	0.78	0.00	0.00	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	152.02	5.16	5.16	7.91	1.72	4.47	1.72	3.10	1.72	0.00
artery, adult	10190-103E1	122.28	2.72	1.36	0.00	0.00	1.36	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	67.22	7.10	3.62	5.07	2.03	5.07	0.72	2.03	0.43	0.14
b cell line:RPMI1788	10427-106D4	80.45	2.53	2.08	3.72	1.04	0.45	1.64	0.89	1.04	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	32.46	2.22	0.83	1.39	0.00	1.11	0.55	0.28	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	87.82	3.37	3.08	0.89	1.98	1.89	0.60	0.30	0.89	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	44.02	0.84	2.85	1.17	1.00	0.33	1.17	0.84	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	75.50	1.12	0.00	2.80	0.56	0.56	1.68	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	49.43	2.61	2.06	1.52	1.41	0.76	0.54	0.33	0.54	0.22
blood, adult, pool1	10053-101G8	84.16	24.36	2.21	0.00	4.43	0.00	4.43	0.00	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	14.56	3.43	2.57	0.86	0.86	0.86	0.00	0.86	0.00	0.86
bone marrow, adult	10192-103E3	56.01	0.67	1.35	4.05	2.02	0.00	1.35	0.67	2.02	0.00
brain, adult, donor1	10084-102B3	57.40	6.15	2.05	3.08	2.05	2.05	2.05	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	58.80	7.13	2.45	1.78	1.45	3.12	0.89	0.11	1.34	0.22
brain, fetal, pool1	10085-102B4	88.16	10.69	2.67	5.34	5.34	21.37	8.01	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	55.50	2.97	2.31	5.29	1.32	0.33	1.32	2.31	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	54.92	2.37	3.50	3.74	2.87	2.00	2.37	1.37	0.12	0.37
breast, adult, donor1	10080-102A8	35.36	1.26	1.89	0.63	0.63	0.00	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	85.88	2.79	4.19	0.51	0.64	0.89	0.13	0.00	1.14	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	52.26	4.33	3.40	5.88	1.55	2.47	1.86	4.02	0.62	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	66.53	2.99	5.53	4.60	2.99	7.14	1.61	0.23	2.99	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	49.87	2.18	1.21	3.15	1.69	1.94	1.69	0.48	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	84.16	5.64	0.94	1.41	0.00	0.94	0.94	1.88	1.41	0.47
carcinoid cell line:NCI-H727	10735-110B6	47.91	1.09	1.64	1.31	0.77	0.55	0.55	0.33	0.33	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	70.03	1.58	2.22	0.32	2.54	0.95	0.63	0.32	2.22	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	88.10	3.73	2.93	6.39	1.06	2.66	1.86	0.80	1.33	1.33
caudate nucleus - adult, donor10196	10177-103C6	70.23	1.15	0.00	2.30	1.15	2.30	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	59.07	7.70	2.51	1.17	2.18	2.18	0.67	0.33	1.84	0.50
caudate nucleus, adult, donor10258	10379-105H1	81.76	1.53	5.35	1.53	0.76	1.53	0.00	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	37.36	1.10	1.10	1.10	1.83	4.76	1.46	1.46	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	113.62	0.00	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	73.02	6.62	2.99	0.64	1.28	4.91	0.43	0.21	1.49	0.43
cerebellum, adult, pool1	10083-102B2	45.53	1.03	1.03	3.10	1.38	0.69	0.34	1.03	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	48.16	3.32	3.32	5.81	3.32	5.81	1.66	0.83	0.00	2.49
cerebral meninges, adult	10188-103D8	46.90	12.10	0.76	2.52	1.01	3.78	0.25	0.25	0.25	1.01
cerebrospinal fluid, donor2	10294-104G6	42.39	1.46	0.73	1.46	0.73	1.46	0.00	0.00	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	89.86	1.73	2.44	3.88	3.45	1.73	3.45	1.01	1.01	0.00
cervical cancer cell line:ME-180	10553-107I4	42.92	1.33	1.49	0.17	0.66	0.33	0.66	0.17	0.17	0.00
cervix, adult, pool1	10013-101C4	61.63	3.57	3.36	0.94	1.99	0.73	0.73	0.42	1.15	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	85.83	3.76	5.29	5.85	2.09	2.37	2.79	2.93	0.84	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	3.92	0.00	0.00	0.00	2.61	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	112.84	2.49	2.98	1.86	1.24	0.25	0.62	0.12	3.11	0.62
choriocarcinoma cell line:SCH	10785-110H2	171.39	13.92	6.65	8.75	1.60	1.60	1.23	2.22	1.36	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	46.49	3.08	2.13	0.71	0.47	0.71	0.00	0.24	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	58.69	3.99	1.99	1.14	0.57	0.00	0.28	0.00	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	51.01	5.37	1.59	1.79	1.19	1.79	1.49	1.39	0.80	0.40
chorionic membrane cells, donor3	12240-129G8	59.89	2.75	3.85	0.00	0.00	0.55	0.55	0.00	3.85	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	89.87	0.00	2.02	0.00	0.00	0.00	0.00	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	112.38	2.11	5.76	1.92	2.69	0.96	2.50	0.38	0.77	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	81.31	4.01	4.22	4.86	2.11	0.63	2.53	1.06	0.63	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	125.83	1.03	6.16	0.77	1.28	0.77	1.54	0.00	1.03	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	137.39	0.97	6.53	0.48	1.45	1.21	1.45	0.48	1.69	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	133.16	0.81	7.33	1.83	2.44	0.61	3.87	0.20	1.83	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	90.99	0.88	3.83	0.29	2.06	0.59	0.59	0.00	0.88	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	142.82	6.26	7.04	5.73	5.73	1.56	5.73	1.82	2.61	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	93.95	5.03	2.29	4.11	0.46	3.89	0.46	0.69	1.83	1.60
clear cell carcinoma cell line:TEN	10636-108I6	47.89	2.08	1.91	1.04	0.69	0.87	0.52	0.17	0.52	0.35
colon carcinoma cell line:CACO-2	10513-107D9	81.27	4.39	1.28	2.38	1.83	2.20	0.73	2.20	0.37	0.18
colon carcinoma cell line:COLO-320	10420-106C6	104.52	2.28	2.28	2.28	0.00	1.14	0.38	0.38	0.76	0.00
colon, adult, donor1	10082-102B1	70.21	1.19	1.19	1.19	2.38	1.19	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	62.51	2.59	1.76	2.23	1.53	0.59	1.18	1.06	1.06	0.24
colon, fetal, donor1	10070-101I7	51.29	3.09	0.00	3.09	1.85	1.24	0.00	0.62	1.85	0.62
common myeloid progenitor CMP, donor1	12130-128D6	132.92	0.00	4.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	58.64	1.27	6.80	3.82	4.25	0.42	0.85	1.27	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	82.41	1.36	4.38	5.28	2.26	0.45	1.36	1.66	0.91	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	88.70	1.69	3.53	4.79	2.40	1.55	1.41	1.27	1.13	0.85
corpus callosum, adult, pool1	10042-101F6	102.82	7.19	3.10	1.55	2.32	2.65	1.55	0.55	1.44	0.11
cruciate ligament, donor2	10295-104G7	47.82	1.62	0.81	1.62	2.43	0.00	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	57.78	4.01	2.41	3.21	2.41	0.80	1.61	0.00	1.61	0.00
diencephalon, adult	10193-103E4	49.92	6.96	2.88	0.72	0.96	1.44	0.48	0.24	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	77.61	1.61	2.98	0.69	0.23	0.69	0.23	0.00	0.69	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	37.95	2.05	1.54	0.51	0.51	1.03	0.51	0.26	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	40.20	3.13	2.17	2.65	3.37	1.93	4.33	4.81	1.44	0.24
ductus deferens, adult	10196-103E7	66.78	1.50	3.99	1.50	0.50	0.00	0.00	0.00	0.00	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	1.44	1.44	4.32	4.32	1.44	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	75.77	0.74	3.68	3.68	2.21	0.74	1.47	0.00	0.00	4.41
dura mater, adult, donor1	10041-101F5	59.88	0.74	3.22	1.65	0.83	0.83	0.83	0.41	0.74	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	168.78	1.33	13.55	3.78	8.66	0.22	4.00	2.00	5.77	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	137.42	2.01	13.04	1.43	3.73	1.00	1.15	0.43	1.72	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	43.16	1.23	2.47	1.23	1.23	1.23	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	54.79	2.72	1.51	1.21	0.30	1.21	0.30	0.61	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	49.09	1.23	0.93	0.62	0.31	0.62	0.31	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	57.79	1.31	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	65.70	3.35	1.68	4.36	2.01	5.03	2.01	0.67	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	71.04	3.81	3.26	3.44	2.36	1.63	1.27	0.54	0.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	49.85	3.06	4.18	3.38	1.29	3.70	1.77	1.45	0.80	0.64
epidermoid carcinoma cell line:A431	10426-106D3	40.24	3.33	2.33	1.33	2.78	0.89	0.56	0.78	0.56	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	74.24	4.07	3.85	0.55	1.21	1.87	0.88	0.22	1.21	0.11
epididymis, adult	10197-103E8	77.86	0.84	0.84	2.09	0.42	0.21	0.84	0.21	1.26	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	59.25	4.79	2.31	1.24	2.31	2.66	2.48	0.53	1.06	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	42.86	0.39	1.97	0.79	0.79	1.18	0.79	0.00	1.18	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	90.03	0.79	7.60	0.26	1.70	0.79	1.05	0.13	2.10	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	78.34	0.69	8.37	0.39	0.39	0.98	0.39	0.20	1.38	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	84.02	1.01	7.39	0.11	1.57	0.45	0.67	0.34	1.34	1.46
esophagus, adult, pool1	10015-101C6	60.42	2.02	2.97	0.42	1.38	0.32	0.42	0.11	1.59	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	76.14	3.63	4.51	2.38	4.63	2.13	4.38	1.50	0.63	0.88
eye - muscle inferior rectus, donor1	10272-104E2	33.80	0.00	2.41	0.00	0.00	0.00	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	52.61	0.00	0.00	4.21	2.10	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	43.16	4.46	0.00	0.00	0.00	0.00	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	48.15	2.29	1.15	0.00	1.15	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	32.06	0.00	4.37	0.00	0.00	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	78.81	5.34	3.05	4.32	2.29	2.54	1.53	2.29	1.78	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	51.80	1.54	2.69	1.28	0.38	1.67	0.64	0.13	0.51	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	108.26	3.32	8.07	1.19	1.66	1.42	0.71	0.71	1.90	0.95
frontal lobe, adult, pool1	10040-101F4	73.28	10.32	2.35	2.81	3.00	4.32	1.03	0.38	1.13	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	71.46	1.80	6.00	1.50	3.00	1.80	2.40	2.40	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	63.00	4.66	2.83	2.56	4.39	3.57	1.55	0.64	0.46	0.37
gall bladder, adult	10198-103E9	69.77	2.66	3.38	3.14	0.48	0.48	1.21	0.97	0.72	0.97
gamma delta positive T cells, donor1	11937-126A2	75.70	1.07	6.98	1.07	2.68	0.54	1.07	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	67.98	0.37	2.24	0.37	3.73	1.49	2.61	0.00	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	66.96	3.38	3.17	4.22	2.75	2.11	3.80	2.11	1.27	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	119.72	4.45	2.13	0.97	1.16	1.93	0.19	0.39	0.19	0.58
gastric cancer cell line:AZ521	10549-107H9	98.05	4.92	3.93	3.61	1.48	4.43	1.97	1.31	0.33	0.16
gastric cancer cell line:GSS	10560-108A2	86.03	0.92	5.49	6.41	0.92	4.58	0.92	0.92	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	76.30	3.43	2.74	2.97	4.80	1.14	2.28	3.66	0.46	1.14
giant cell carcinoma cell line:LU65	10487-107B1	68.84	1.15	3.67	1.95	1.49	0.34	2.29	0.80	0.69	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	152.42	5.88	11.62	13.44	3.22	0.70	3.22	4.90	1.26	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	39.91	2.24	2.74	0.50	2.00	0.75	0.75	0.75	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	34.20	1.69	2.43	2.74	3.48	1.90	2.22	2.01	0.74	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	29.21	2.81	1.83	2.81	3.23	1.97	1.12	1.83	0.14	0.14
glioblastoma cell line:T98G	10485-107A8	55.63	3.53	2.54	3.64	1.43	3.09	2.43	1.21	0.77	0.22
glioma cell line:GI-1	10413-106B8	61.80	9.08	1.76	7.03	2.93	6.74	0.59	4.10	1.17	0.00
globus pallidus - adult, donor10196	10175-103C4	50.29	1.46	2.92	0.73	0.00	1.46	1.46	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	66.88	6.59	1.22	2.20	1.95	1.95	0.49	0.49	0.98	0.73
globus pallidus, adult, donor10258	10367-105F7	65.72	0.00	1.37	1.37	1.37	0.00	0.00	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	37.84	0.00	0.53	1.60	1.60	3.73	1.07	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	159.06	0.00	9.79	2.45	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	24.32	4.16	1.60	2.56	0.64	0.96	0.32	1.28	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	57.39	1.84	2.75	2.30	0.00	2.30	0.46	0.92	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	54.87	4.12	3.66	0.91	0.00	1.37	0.46	0.91	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	80.51	1.29	7.73	1.29	0.00	1.29	0.64	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	48.87	1.44	11.50	1.44	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	55.56	1.37	6.17	1.37	0.69	2.74	0.69	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	46.35	3.31	2.21	0.00	0.00	1.10	1.10	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	73.56	2.59	2.59	5.75	2.30	1.72	0.86	3.16	0.57	0.29
heart - mitral valve, adult	10205-103F7	65.77	0.90	2.69	0.60	0.90	0.60	1.49	0.00	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	77.66	4.18	1.57	1.83	0.26	0.78	0.00	0.26	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	70.77	2.50	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	110.39	3.26	4.29	2.86	0.61	3.67	1.43	0.82	1.43	0.41
heart, adult, diseased, donor1	10051-101G6	145.21	2.13	4.68	2.98	1.28	1.70	0.85	0.43	1.70	0.85
heart, adult, pool1	10016-101C7	81.41	2.30	1.61	0.46	2.30	0.23	0.46	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	144.98	6.26	4.11	6.47	3.90	4.21	2.36	3.08	1.64	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	23.14	3.09	1.85	0.62	0.62	1.54	0.62	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	53.51	1.19	1.19	1.19	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	123.98	9.61	8.95	6.30	4.97	5.08	2.32	4.75	3.54	1.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	129.26	10.56	8.86	5.10	5.46	4.98	2.79	5.34	3.52	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	139.96	10.21	8.29	5.15	3.44	4.45	2.43	5.86	4.04	2.53
hepatoma cell line:Li-7	10484-107A7	58.83	2.34	2.78	2.89	1.67	1.78	1.78	2.45	1.22	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	84.02	2.41	3.42	0.30	0.90	0.30	0.80	0.20	0.60	0.10
hippocampus - adult, donor10196	10169-103B7	44.48	3.79	5.68	0.00	0.00	2.84	1.89	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	54.09	7.55	3.67	1.02	1.22	3.06	0.82	0.41	1.02	0.61
hippocampus, adult, donor10258	10374-105G5	40.83	2.49	4.48	2.49	0.00	2.99	1.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	33.13	1.06	2.82	0.35	1.06	3.52	0.35	0.00	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	72.02	4.88	4.88	6.10	3.05	2.44	2.44	2.44	1.83	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	60.48	3.53	6.68	2.75	1.57	1.77	1.37	2.36	1.57	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	75.15	3.30	6.60	3.30	2.29	3.55	2.03	2.29	2.29	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	80.07	3.95	2.82	7.33	3.38	3.38	0.56	2.26	5.07	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	78.24	5.94	2.07	5.16	5.16	5.16	1.03	4.65	9.81	3.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	74.40	6.07	3.04	6.07	6.83	3.04	3.04	4.56	3.04	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	66.57	3.50	4.09	8.47	6.42	5.84	2.34	8.17	2.92	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	70.88	6.03	2.80	10.13	6.03	4.74	3.66	6.25	6.68	2.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	68.40	5.00	4.17	4.17	3.75	4.59	4.17	1.67	4.59	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	73.64	6.16	4.03	6.16	3.79	2.60	1.89	4.26	1.89	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	71.84	5.30	3.38	5.46	5.79	4.34	2.89	3.21	2.09	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	70.70	6.06	4.71	3.37	2.69	2.69	2.02	2.02	1.35	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	55.86	4.38	4.23	2.35	2.82	1.72	0.16	2.50	4.23	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	52.08	4.91	2.46	2.46	4.42	0.98	0.98	1.97	0.49	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	45.38	0.00	6.11	3.49	0.87	4.36	3.49	3.49	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	80.76	4.58	3.05	6.68	7.83	3.44	3.63	4.01	5.15	1.91
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	68.03	3.92	3.92	6.11	3.92	3.05	1.74	2.62	2.18	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	65.47	5.00	3.50	9.00	6.00	3.00	3.00	6.50	2.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	75.73	2.64	2.26	12.06	6.78	2.45	4.71	6.59	5.09	2.07
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	69.12	5.00	2.27	10.00	5.91	5.46	4.55	7.28	5.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	74.24	3.13	2.19	9.71	5.64	1.25	2.51	5.01	4.07	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	55.03	2.12	2.61	11.10	6.70	4.57	3.27	7.02	1.63	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	51.68	1.45	2.32	10.16	4.35	3.48	4.94	3.77	1.45	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	50.82	1.49	2.99	10.46	2.09	3.89	2.99	6.88	1.20	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	63.00	3.69	6.28	2.59	1.48	1.11	1.11	2.59	2.03	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	63.33	5.14	2.57	4.85	1.71	2.85	2.57	2.00	2.28	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	72.68	8.98	6.12	5.31	3.27	3.27	0.41	3.67	1.22	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	69.71	11.27	2.82	9.51	0.70	4.58	2.46	7.04	3.17	2.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	54.48	3.48	1.27	8.24	3.17	2.22	1.27	5.70	4.12	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	66.58	3.63	3.93	10.29	2.72	3.63	1.82	5.45	4.24	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	51.71	1.55	1.55	9.31	2.59	4.65	3.10	5.69	2.59	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	54.46	5.31	3.98	9.30	3.32	3.32	1.99	8.63	0.66	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	58.49	0.77	1.54	9.24	2.82	1.28	1.54	4.87	1.54	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	64.17	3.83	2.81	6.90	2.05	4.09	1.53	4.86	3.32	2.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	59.06	0.76	1.51	12.12	3.79	5.30	3.79	4.54	1.51	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	56.12	1.34	2.02	10.75	3.36	5.04	1.01	1.68	3.70	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	57.24	6.52	4.59	2.42	1.21	1.21	0.48	1.93	2.17	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	53.03	1.34	5.79	4.01	2.67	0.00	1.34	2.23	0.89	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	73.66	2.93	8.29	4.39	1.46	2.44	0.49	1.95	0.98	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	72.13	7.33	2.14	7.03	5.81	2.75	2.75	7.03	4.28	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	139.89	29.28	0.00	32.53	13.01	16.27	16.27	32.53	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	85.38	8.27	3.31	8.60	3.64	3.31	3.31	3.64	6.95	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	64.58	3.28	5.47	8.21	0.00	4.38	2.19	2.74	1.64	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	56.45	2.90	2.53	5.79	4.34	4.70	1.45	4.70	2.90	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	57.65	4.27	2.49	7.47	2.49	5.34	2.85	4.63	2.49	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	48.93	2.39	1.19	7.16	1.19	3.58	2.39	1.19	1.19	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	80.71	7.18	3.93	7.72	5.28	6.91	3.79	5.01	5.28	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	56.03	2.96	5.66	5.93	4.58	3.50	2.42	2.69	3.50	0.54
immature langerhans cells, donor1	11904-125F5	51.34	1.21	1.70	1.70	0.97	0.00	1.21	0.97	0.00	0.00
immature langerhans cells, donor2	11905-125F6	49.90	2.38	0.79	2.38	3.17	0.79	0.00	1.58	0.00	0.79
insula, adult, pool1	10039-101F3	81.10	8.33	2.56	3.79	2.18	6.81	2.84	0.47	1.32	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	46.17	1.95	1.63	0.98	0.65	0.65	0.65	0.33	0.33	0.00
kidney, adult, pool1	10017-101C8	65.78	3.50	3.80	1.70	2.30	2.00	2.00	0.20	1.30	0.70
kidney, fetal, pool1	10045-101F9	96.91	6.15	5.16	3.75	4.46	2.90	3.75	1.63	1.63	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	116.46	6.67	1.85	1.42	3.69	1.42	2.56	0.14	1.70	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	38.71	1.80	1.24	0.69	0.28	0.69	0.28	0.14	0.41	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	48.63	3.12	2.39	0.92	1.47	1.28	0.55	0.18	0.00	0.00
left atrium, adult, donor1	10079-102A7	57.21	2.72	1.09	1.09	1.09	0.00	1.09	0.54	0.54	0.54
left ventricle, adult, donor1	10078-102A6	64.22	2.02	1.01	0.51	0.51	1.01	0.51	0.00	2.02	0.51
leiomyoblastoma cell line:G-402	10721-110A1	30.10	1.92	2.46	1.92	0.55	3.01	1.64	1.92	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	26.58	3.95	3.23	8.26	2.16	1.08	2.87	0.72	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	20.11	3.26	1.63	3.80	0.54	1.09	1.63	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	30.84	3.64	1.70	4.37	0.97	2.67	1.21	0.73	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	64.82	4.18	1.05	2.09	1.05	0.00	2.09	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	88.07	6.14	5.67	6.49	5.67	2.24	5.67	3.19	1.30	0.12
liposarcoma cell line:KMLS-1	10782-110G8	31.87	2.50	1.56	3.91	1.72	2.97	1.72	2.34	0.47	0.16
liposarcoma cell line:SW 872	10726-110A6	72.01	3.41	2.68	0.12	1.22	4.51	0.61	0.61	0.73	0.00
liver, adult, pool1	10018-101C9	99.83	1.30	6.16	1.78	4.05	0.81	4.05	2.59	2.11	0.49
liver, fetal, pool1	10086-102B5	59.26	0.94	1.88	1.88	2.82	2.82	0.00	2.82	2.82	0.00
locus coeruleus - adult, donor10196	10182-103D2	33.25	4.23	1.46	1.17	1.75	2.04	0.73	0.87	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	50.38	5.17	1.48	1.48	2.21	2.95	0.74	0.55	0.55	0.74
locus coeruleus, adult, donor10258	10375-105G6	36.40	0.56	1.69	1.69	0.85	1.41	0.00	1.13	1.13	0.56
locus coeruleus, newborn, donor10223	10362-105F2	43.32	1.68	0.84	2.10	3.79	2.94	0.84	0.42	1.68	0.42
lung adenocarcinoma cell line:A549	10499-107C4	19.65	3.46	1.38	1.38	0.28	0.97	0.55	0.14	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	39.99	3.45	2.07	1.38	2.07	2.76	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	59.98	4.88	1.05	1.71	1.71	0.40	1.32	0.26	0.53	0.00
lung, adult, pool1	10019-101D1	61.90	1.89	2.24	1.54	0.95	0.47	0.59	0.47	0.83	0.00
lung, fetal, donor1	10068-101I5	99.04	6.56	4.00	2.57	2.00	1.14	4.57	0.57	1.43	0.86
lung, right lower lobe, adult, donor1	10075-102A3	58.19	0.92	2.75	1.37	1.83	0.00	0.46	1.37	2.29	0.00
lymph node, adult, donor1	10077-102A5	47.34	0.00	4.73	1.42	0.47	1.42	0.00	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	71.23	2.41	1.75	0.44	0.22	0.44	0.00	0.44	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	64.14	2.41	3.92	0.00	0.00	0.45	0.45	0.00	0.45	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	37.38	0.85	0.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	52.39	2.66	2.22	1.33	0.00	0.00	1.33	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	51.47	6.43	1.66	0.62	1.04	0.00	0.83	0.42	0.00	0.00
mature adipocyte, donor3	12233-129G1	54.29	3.08	1.90	1.19	2.61	0.24	1.42	0.24	0.47	0.00
mature adipocyte, donor4	12234-129G2	52.64	3.69	2.11	3.69	1.32	1.05	1.32	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	63.85	3.81	1.19	3.34	2.62	0.95	0.48	1.19	1.19	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	38.35	2.26	2.26	0.00	0.00	4.51	1.13	0.00	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	47.82	6.07	2.21	2.39	1.47	4.78	0.37	0.18	0.92	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	42.57	1.27	3.18	1.27	0.64	1.27	0.64	0.32	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	38.38	6.82	2.13	5.54	3.41	7.25	2.56	1.71	0.00	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	55.69	3.88	3.21	3.71	0.84	4.22	0.17	0.17	2.53	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	54.75	8.28	2.12	1.49	1.06	3.18	0.85	0.64	0.85	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	88.61	0.00	3.85	1.93	1.93	5.78	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	28.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	34.82	0.36	2.15	3.23	1.79	5.03	1.79	1.44	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	48.02	2.60	1.30	0.65	0.65	2.60	1.95	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	58.21	5.88	3.25	0.46	1.55	3.10	0.77	0.15	1.55	0.77
medulla oblongata, adult, pool1	10038-101F2	61.06	7.43	1.88	2.78	2.37	2.94	0.82	0.65	1.14	0.16
medulla oblongata, newborn, donor10223	10361-105F1	38.88	1.04	2.08	1.39	1.74	2.78	0.00	0.00	1.74	0.35
medulloblastoma cell line:D283 Med	10838-111E1	165.39	3.32	8.41	10.63	0.66	1.55	2.66	4.65	3.10	1.11
medulloblastoma cell line:ONS-76	10759-110E3	54.41	2.93	2.08	1.10	2.32	3.06	0.61	1.10	0.24	0.00
melanoma cell line:COLO 679	10514-107E1	56.64	0.43	2.16	1.44	1.72	0.72	2.44	0.57	0.72	0.00
melanoma cell line:G-361	10465-106H6	40.99	3.53	1.90	1.09	1.36	1.36	4.07	1.09	1.36	0.00
meningioma cell line:HKBMM	10691-109F7	48.12	2.53	1.09	0.54	0.54	0.54	0.54	0.18	0.18	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	121.60	5.29	5.29	4.41	2.64	3.52	2.64	2.64	3.52	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	128.06	3.37	5.44	2.33	3.11	3.89	1.81	1.81	1.04	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	49.56	7.67	3.99	2.30	2.45	2.30	1.69	1.38	0.92	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	35.81	4.18	1.27	3.27	1.64	2.18	0.73	1.09	0.55	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	41.00	4.56	1.66	3.31	1.66	1.24	2.07	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	36.80	7.16	0.98	5.76	0.84	4.78	0.84	2.53	1.40	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	29.66	5.01	1.16	4.24	3.08	2.70	2.31	2.70	0.58	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	22.90	0.69	2.08	6.25	2.08	3.47	2.08	0.69	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	32.10	7.04	1.89	3.26	1.54	1.20	0.34	1.72	0.51	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	34.50	5.87	1.96	3.68	1.15	0.81	0.92	1.27	0.92	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	42.05	5.97	1.86	2.12	2.52	2.65	1.72	1.46	0.53	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	44.02	6.21	2.16	1.89	2.84	1.89	2.03	1.49	0.54	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	37.56	8.39	2.13	2.85	2.28	2.99	1.28	1.00	0.57	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	39.52	1.32	1.65	2.31	2.31	0.66	1.65	1.98	0.99	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	31.27	6.92	2.08	1.94	1.66	2.49	1.25	1.25	0.55	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	42.94	4.54	3.14	1.05	1.75	1.75	1.75	1.05	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	29.60	7.55	0.82	1.84	1.02	0.61	1.02	0.82	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	29.48	1.44	1.80	2.16	2.88	0.72	2.88	2.88	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	33.52	7.14	1.86	2.07	1.76	2.90	1.03	1.24	0.52	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	21.43	1.37	1.60	1.37	1.60	2.28	1.37	0.91	1.37	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	31.47	6.29	3.36	2.52	3.78	3.36	2.52	2.52	0.84	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	35.57	8.07	2.39	3.59	2.54	1.79	1.79	0.75	0.45	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	34.22	7.18	1.93	2.10	2.01	2.71	1.40	1.23	0.96	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	41.97	1.84	2.58	1.47	1.84	2.58	2.21	0.37	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	38.06	1.14	2.00	2.29	2.58	2.58	0.86	1.43	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	54.31	3.79	2.53	5.47	0.42	2.53	0.42	2.53	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	32.88	4.11	0.91	1.83	1.37	2.28	0.46	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	29.67	4.09	1.28	2.30	0.77	2.05	0.51	1.02	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	31.67	2.88	1.57	3.40	1.05	2.09	1.05	1.05	0.52	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	40.05	1.54	1.54	2.46	1.23	0.62	0.92	0.00	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	30.13	2.35	1.41	2.82	0.71	1.65	0.47	2.12	1.18	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	36.89	2.71	1.02	3.38	0.34	2.03	0.68	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	38.12	4.32	1.96	2.75	0.39	2.36	0.39	0.79	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	32.44	1.39	2.32	1.39	1.39	1.39	1.39	0.46	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	44.42	4.33	4.04	3.46	0.29	2.60	1.73	1.15	0.58	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	30.34	3.35	2.23	2.01	1.12	0.67	0.22	1.56	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	35.81	2.88	3.36	2.40	0.96	2.16	2.16	1.20	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	21.27	3.67	1.47	0.73	0.00	0.73	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	40.61	2.01	2.01	1.34	0.34	1.34	1.68	1.01	1.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	32.34	1.64	3.28	1.64	1.64	0.82	0.82	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	36.08	4.30	1.29	4.30	0.00	2.15	1.29	0.86	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	46.48	2.73	5.47	5.47	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	0.00	5.16	0.00	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	36.05	2.27	2.92	3.90	0.97	1.62	0.65	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	37.83	5.82	1.45	0.00	1.45	2.91	1.45	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	30.92	0.00	1.60	2.67	1.60	0.53	0.00	1.07	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	31.89	0.82	0.82	1.64	0.00	2.45	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	34.21	2.33	1.94	1.55	2.33	1.55	0.39	1.17	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	0.00	0.00	4.20	0.00	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	30.80	0.00	1.99	2.98	0.99	2.98	1.99	0.00	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	4.77	0.00	4.77	0.00	4.77	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	21.94	2.37	3.56	1.19	1.19	2.37	1.78	1.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	28.02	1.22	0.00	4.87	0.00	6.09	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	32.94	2.53	2.53	2.53	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	24.49	1.72	0.69	2.76	0.00	2.41	0.69	1.38	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	0.00	0.00	4.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	0.00	3.99	0.00	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	3.44	0.00	6.89	0.00	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	18.34	2.04	2.44	4.89	0.41	2.44	0.00	1.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	12.71	1.59	0.79	4.77	0.79	2.38	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.63	0.59	0.59	7.07	1.18	2.95	0.00	1.18	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.20	1.25	0.62	4.99	1.25	1.87	0.00	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	26.73	0.00	0.00	13.37	0.00	2.67	2.67	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	3.55	2.37	3.55	0.00	1.18	3.55	3.55	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	0.00	2.57	7.70	5.14	2.57	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	40.62	1.38	1.38	6.20	1.38	1.38	2.07	1.38	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	47.01	1.48	2.97	3.46	0.49	0.49	0.49	1.48	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	42.62	4.49	0.00	3.36	1.12	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	49.61	2.54	1.91	3.82	0.64	0.64	1.27	0.64	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	47.95	2.42	2.01	3.22	2.42	0.81	2.01	0.81	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	41.43	4.36	0.00	0.00	0.00	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	45.61	1.27	2.53	6.34	0.00	1.27	2.53	0.00	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	40.66	6.07	2.43	8.50	1.82	0.00	0.61	1.21	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	58.75	4.52	0.00	4.52	4.52	0.00	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	39.54	0.00	0.00	7.41	0.00	0.00	3.29	2.47	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	25.20	0.60	0.40	0.99	0.40	0.20	0.79	0.79	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	31.48	0.65	2.60	2.27	0.32	1.62	0.00	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	28.52	0.00	2.04	2.04	0.00	1.02	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.85	0.77	1.55	0.77	1.55	1.55	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	55.04	4.96	1.65	2.36	0.24	1.42	0.00	0.00	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	41.93	2.78	1.85	4.17	2.09	4.40	0.70	3.48	1.16	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	8.55	0.00	0.00	0.00	0.00	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	31.65	2.06	2.06	1.54	2.98	1.54	1.75	0.51	0.10	0.21
mesothelioma cell line:Mero-25	10850-111F4	83.07	0.23	6.13	0.68	0.91	0.00	1.13	0.00	0.68	0.68
mesothelioma cell line:Mero-41	10851-111F5	77.50	1.71	4.16	0.73	0.98	1.22	1.71	0.24	1.22	0.24
mesothelioma cell line:Mero-48a	10852-111F6	54.69	1.77	1.99	1.11	0.66	1.77	0.44	0.22	0.66	0.00
mesothelioma cell line:Mero-82	10853-111F7	67.02	1.05	3.42	1.84	0.79	1.05	0.53	0.26	1.31	0.26
mesothelioma cell line:Mero-83	10854-111F8	59.75	3.40	3.92	5.28	1.19	4.09	2.04	2.04	0.85	0.85
mesothelioma cell line:Mero-84	10855-111F9	49.54	3.79	3.54	1.01	3.29	1.26	0.25	0.51	0.76	0.76
mesothelioma cell line:Mero-95	10856-111G1	49.90	1.66	1.66	2.28	0.83	1.66	0.00	0.83	1.04	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	48.04	0.83	2.48	0.50	0.17	1.16	0.17	0.17	0.66	0.50
mesothelioma cell line:NCI-H226	10846-111E9	49.59	1.99	3.62	2.35	0.54	0.54	0.72	0.00	1.09	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	86.78	2.56	4.78	5.12	1.37	0.68	1.02	1.20	1.71	0.17
mesothelioma cell line:NCI-H28	10845-111E8	74.30	2.80	2.80	3.82	2.29	3.31	1.02	1.78	1.02	0.25
mesothelioma cell line:No36	10857-111G2	79.59	3.26	3.91	0.65	1.30	0.65	0.33	0.00	2.28	0.98
mesothelioma cell line:ONE58	10858-111G3	81.83	2.17	2.71	8.40	1.35	2.17	2.44	2.17	1.63	0.81
migratory langerhans cells, donor1	11901-125F2	48.75	2.49	3.45	4.80	1.15	0.19	0.77	0.96	0.19	0.38
migratory langerhans cells, donor2	11902-125F3	66.80	1.59	3.42	2.56	0.73	0.61	0.24	0.37	0.61	0.24
migratory langerhans cells, donor3	11903-125F4	42.00	1.08	1.97	1.26	1.08	0.18	0.36	0.18	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	105.13	2.29	3.26	0.65	2.29	1.96	0.98	0.00	2.61	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	47.47	3.18	2.54	0.85	1.06	4.24	0.85	0.21	0.64	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	51.14	2.99	1.84	0.23	1.15	0.00	0.23	0.69	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	60.70	1.90	3.43	2.85	2.09	0.00	0.57	0.57	1.33	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	114.94	2.40	3.70	0.55	1.11	0.00	0.18	0.37	1.29	0.18
myeloma cell line:PCM6	10474-106I6	54.16	3.36	3.95	2.57	1.98	0.00	1.38	0.20	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	24.86	3.04	1.01	0.00	0.00	1.01	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	49.82	3.73	2.94	1.57	1.18	0.39	0.59	0.00	0.59	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	34.43	4.79	1.11	0.45	0.56	0.22	0.78	0.67	0.22	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	25.52	3.09	1.10	1.32	0.29	0.22	0.74	0.66	0.37	0.22
nasal epithelial cells, donor2	12227-129F4	30.36	2.21	1.10	0.55	1.66	0.00	1.66	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	97.09	7.59	2.99	4.37	2.99	2.30	1.38	2.07	1.61	0.23
neuroblastoma cell line:NB-1	10539-107G8	93.54	11.79	3.55	5.61	6.36	4.86	2.43	1.68	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	105.02	9.07	4.43	3.37	1.90	9.07	0.84	1.48	0.84	0.84
neuroblastoma cell line:NH-12	10555-107I6	114.61	9.50	6.34	5.22	1.86	0.93	2.05	2.42	0.19	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	50.29	4.98	2.61	5.69	2.85	4.03	1.66	0.95	0.95	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	78.87	6.65	1.90	3.17	3.17	3.33	1.74	0.79	1.58	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	57.96	6.64	2.82	1.81	2.01	2.62	1.41	0.20	0.20	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	47.68	1.27	1.27	0.00	0.00	0.00	1.27	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	29.81	1.06	2.40	0.80	2.40	1.60	1.06	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	59.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	104.35	2.37	2.37	7.44	3.72	1.18	1.52	3.38	0.85	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	35.22	3.20	0.00	7.20	0.00	4.80	1.60	3.20	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	35.59	1.60	1.60	2.56	1.60	1.92	1.28	0.32	0.96	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	28.12	2.89	1.31	3.15	1.31	0.53	1.58	1.31	1.58	0.79
nucleus accumbens, adult, pool1	10037-101F1	83.33	9.84	2.81	1.97	1.50	4.03	1.78	0.75	1.22	0.37
occipital cortex - adult, donor10196	10172-103C1	61.81	4.12	6.18	4.12	2.06	0.00	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	51.26	7.78	1.34	0.81	1.34	2.68	1.07	0.54	1.34	0.27
occipital cortex, newborn, donor10223	10355-105E4	49.50	1.09	1.46	1.46	2.18	5.10	1.46	1.46	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	45.40	8.13	1.57	1.84	1.31	1.84	1.05	0.52	0.26	1.57
occipital lobe, fetal, donor1	10073-102A1	60.07	13.73	2.57	7.29	1.29	28.75	3.43	0.86	1.72	0.43
occipital pole, adult, pool1	10036-101E9	90.12	11.12	2.84	1.81	1.42	2.68	1.02	0.47	1.18	0.24
olfactory region, adult	10195-103E6	46.62	7.45	1.91	1.53	0.57	4.01	0.38	0.38	0.38	0.57
optic nerve, donor1	10277-104E7	56.03	2.00	0.00	0.00	4.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	54.68	2.62	2.39	1.03	2.16	2.28	1.37	1.71	1.48	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	43.69	3.57	1.92	2.61	0.96	0.55	1.10	0.55	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	58.42	7.62	3.73	3.56	1.86	1.52	1.52	0.68	3.56	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	41.70	2.19	2.54	0.69	0.69	0.23	0.46	0.35	0.81	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	38.22	0.59	0.88	0.59	1.18	0.59	0.00	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	98.11	0.00	4.67	0.93	0.93	0.93	0.93	0.93	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	113.03	4.88	5.73	3.18	2.76	2.12	2.12	2.33	1.06	0.21
ovary, adult, pool1	10020-101D2	65.60	4.19	4.63	1.05	3.14	0.96	1.83	0.09	0.96	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	41.06	2.02	1.83	2.02	1.65	1.83	0.73	0.37	0.73	0.00
pancreas, adult, donor1	10049-101G4	67.73	4.70	3.76	0.00	0.94	1.88	0.00	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	70.16	1.40	2.52	3.91	0.84	0.84	0.28	0.84	1.40	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	88.24	1.36	3.07	1.36	1.53	1.70	0.51	0.17	2.56	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	44.38	1.99	0.99	1.82	2.81	1.16	1.16	1.49	0.99	0.17
paracentral gyrus, adult, pool1	10035-101E8	72.03	8.69	1.83	2.29	1.56	3.48	1.19	0.55	1.10	0.09
parietal cortex, adult, donor10258	10373-105G4	48.44	2.20	3.67	0.73	0.00	2.94	0.00	0.73	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	35.74	7.52	1.88	1.88	0.94	6.58	0.00	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	43.61	6.84	1.71	1.14	0.86	2.85	0.57	0.00	1.14	0.57
parietal lobe, adult, pool1	10034-101E7	70.67	12.69	2.91	3.35	2.82	4.23	0.70	0.35	1.06	0.35
parietal lobe, fetal, donor1	10072-101I9	66.92	5.82	1.94	4.85	4.85	17.46	2.91	0.97	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	37.01	3.36	2.62	3.36	1.87	7.48	0.75	0.37	0.75	0.37
parotid gland, adult	10199-103F1	83.87	4.32	2.47	1.85	0.00	0.62	1.23	0.00	1.85	1.23
penis, adult	10200-103F2	63.38	1.61	2.69	0.54	1.07	0.54	0.54	0.00	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	100.59	10.41	5.39	2.42	4.46	3.72	2.60	1.30	1.86	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	57.55	1.75	2.04	0.87	1.02	0.73	0.73	0.15	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	59.99	9.68	1.94	3.87	4.52	7.74	1.94	2.58	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	87.65	11.25	2.96	7.70	4.15	9.48	1.78	7.11	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	56.44	0.63	1.88	3.76	0.63	5.02	0.00	3.76	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	66.78	5.06	1.01	4.05	2.02	6.07	1.01	1.01	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	101.63	8.86	3.13	5.21	0.52	3.65	0.00	1.56	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	53.63	0.85	0.00	4.26	0.00	1.70	1.70	0.85	1.70	0.85
placenta, adult, pool1	10021-101D3	88.37	1.83	4.09	0.75	1.08	0.11	0.54	0.11	0.65	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	70.45	1.85	2.91	1.59	0.53	0.53	0.53	0.00	1.32	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	61.48	4.20	1.87	1.56	1.25	1.25	0.31	0.62	0.78	0.31
pons, adult, pool1	10033-101E6	58.96	5.25	1.89	1.89	2.75	2.67	1.38	0.86	0.60	0.17
postcentral gyrus, adult, pool1	10032-101E5	79.59	11.16	2.96	2.44	2.01	4.01	1.22	0.52	1.22	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	150.58	2.09	2.09	0.00	2.09	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	76.47	6.12	2.48	3.35	1.46	2.33	1.89	1.17	1.60	0.58
prostate cancer cell line:PC-3	10439-106E7	76.23	3.81	2.36	2.72	2.36	3.63	1.27	2.18	0.00	0.18
prostate, adult, pool1	10022-101D4	60.49	3.45	3.72	1.45	1.45	0.91	1.27	0.27	1.18	0.36
putamen, adult, donor10196	10176-103C5	66.81	7.08	4.01	0.71	1.18	3.78	0.00	0.00	2.60	1.18
putamen, adult, donor10252	10152-102I8	50.98	3.92	0.00	1.96	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	68.85	1.09	4.37	0.00	0.00	1.09	0.00	2.19	0.00	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	75.87	0.97	1.93	0.97	0.24	1.21	0.48	0.00	0.72	0.00
putamen, newborn, donor10223	10365-105F5	42.73	3.75	1.50	3.00	0.75	3.75	0.75	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	59.93	2.91	0.58	2.04	0.58	0.58	0.87	0.29	0.29	0.00
rectum, fetal, donor1	10067-101I4	63.99	1.39	0.00	2.78	4.17	1.39	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	30.74	1.48	0.85	0.64	0.42	0.85	0.42	0.00	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	66.69	4.14	1.66	4.14	6.63	4.97	1.24	2.07	0.83	0.00
retina, adult, pool1	10030-101E3	99.20	7.36	5.47	1.99	1.69	2.48	1.29	1.09	1.69	0.70
retinoblastoma cell line:Y79	10475-106I7	177.96	7.79	8.31	19.74	1.56	3.90	1.04	17.93	1.30	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	61.60	4.30	3.81	0.37	1.35	2.46	0.61	0.25	0.61	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	75.92	5.62	5.06	1.69	0.28	1.69	2.53	0.84	0.84	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	30.31	2.27	1.52	0.76	0.00	2.27	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	40.14	2.75	2.59	6.64	2.10	1.46	1.46	1.46	0.49	0.16
salivary acinar cells, donor2	11772-123I8	59.21	2.20	3.58	7.02	0.69	0.41	1.65	2.07	1.24	0.41
salivary acinar cells, donor3	11773-123I9	49.65	5.30	1.99	7.94	1.32	0.66	0.00	1.99	0.00	0.00
salivary gland, adult, pool1	10093-102C3	90.94	5.15	4.58	2.29	0.57	0.00	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	71.66	3.04	3.88	7.84	2.70	1.35	2.28	3.04	2.11	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	66.42	5.88	2.82	5.64	2.47	1.76	2.12	1.29	0.94	0.35
seminal vesicle, adult	10201-103F3	68.78	1.59	6.88	1.06	0.00	0.53	1.06	0.53	1.59	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	56.36	0.97	5.10	2.43	0.97	0.97	1.46	0.49	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	60.89	2.77	1.76	0.75	1.01	1.51	1.01	0.50	0.75	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	75.26	1.00	4.01	2.01	1.00	3.01	1.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	113.37	2.96	6.85	1.61	0.94	1.88	1.21	1.21	1.75	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	94.39	3.32	3.65	1.11	1.22	0.88	1.88	0.88	1.22	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	43.87	2.06	2.45	1.68	1.42	1.42	1.29	1.68	0.39	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	70.93	2.84	2.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	174.27	1.68	2.16	0.96	0.96	0.00	0.96	0.24	2.16	0.96
skeletal muscle, fetal, donor1	10066-101I3	90.45	5.03	0.00	5.03	1.01	1.01	3.02	1.01	1.01	0.00
skin, adult, donor1	10074-102A2	13.57	6.79	6.79	0.00	0.00	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	52.39	3.16	3.16	3.16	1.89	0.00	2.52	0.00	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	66.70	2.00	2.67	4.34	1.33	2.67	1.67	1.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	102.44	5.36	2.21	12.29	4.73	4.73	5.67	12.61	2.52	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	143.60	17.15	3.66	7.13	2.70	11.18	3.08	0.58	1.93	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	74.34	3.96	2.31	4.29	2.80	0.49	2.64	1.48	1.65	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	219.24	4.02	6.92	2.25	1.13	0.80	0.48	2.57	3.54	1.93
small cell lung carcinoma cell line:WA-hT	10562-108A4	101.77	5.23	1.31	7.85	3.05	2.83	3.70	3.05	0.44	0.22
small intestine, adult, pool1	10024-101D6	108.22	3.34	5.02	2.63	5.14	0.72	3.82	2.87	2.27	0.60
small intestine, fetal, donor1	10064-101I1	53.81	0.98	1.47	0.74	1.72	0.98	1.97	0.74	0.98	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	81.55	3.08	4.10	4.62	5.13	1.03	3.59	4.10	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	49.11	3.36	2.07	1.81	0.52	0.26	0.26	0.52	1.29	0.26
somatostatinoma cell line:QGP-1	10781-110G7	41.01	2.41	0.27	5.90	2.14	1.07	3.22	6.43	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	34.87	3.67	2.29	1.15	0.69	1.84	0.46	0.23	1.38	0.00
spinal cord, adult, donor10252	10159-103A6	44.16	3.55	1.97	0.39	0.79	2.37	0.39	0.39	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	35.97	3.46	1.38	0.69	1.38	0.69	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	67.08	8.54	2.44	1.83	3.05	5.49	1.22	0.00	0.00	1.83
spinal cord, newborn, donor10223	10359-105E8	50.51	2.30	3.21	1.38	1.84	2.30	0.92	0.00	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	28.08	1.79	1.34	0.75	0.15	1.34	0.60	0.15	0.15	0.00
spleen, adult, pool1	10025-101D7	77.31	1.65	3.85	0.99	1.10	0.33	0.88	0.44	2.53	0.22
spleen, fetal, pool1	10044-101F8	94.00	3.81	3.34	1.27	1.83	0.48	1.43	0.16	0.56	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	48.44	1.86	2.38	1.55	0.62	0.41	0.21	0.10	0.41	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	45.00	1.90	1.71	1.33	1.33	0.38	0.76	0.76	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	112.52	5.24	4.54	6.64	1.05	4.19	3.84	1.05	3.49	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	50.82	1.17	3.91	1.56	1.95	0.39	1.17	0.39	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	94.55	2.03	2.70	2.14	4.61	1.35	3.60	1.91	0.68	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	56.76	1.69	4.66	2.12	1.27	0.42	0.42	1.69	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	77.00	2.54	3.38	2.12	0.00	2.12	0.85	0.00	0.85	0.00
stomach, fetal, donor1	10062-101H8	44.85	1.07	3.20	0.00	1.07	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	75.20	1.71	2.85	0.00	1.14	0.57	0.57	0.00	1.71	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	62.52	4.57	2.91	1.04	2.28	2.91	0.42	0.21	1.04	0.42
substantia nigra, adult, donor10258	10371-105G2	45.52	0.52	3.62	0.52	0.00	2.59	0.52	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	39.57	0.00	0.71	2.12	0.71	4.95	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	72.68	9.86	2.98	6.65	2.06	4.59	1.38	1.60	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	83.58	9.16	3.48	2.03	2.29	4.75	1.78	0.25	1.44	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	59.12	22.79	0.71	4.99	5.70	32.76	2.14	0.00	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	83.51	13.19	0.88	7.03	8.35	25.05	3.96	1.76	0.88	1.76
tenocyte, donor1	11763-123H8	38.05	2.44	1.75	2.09	2.09	3.14	0.70	0.70	3.14	1.05
tenocyte, donor2	11765-123I1	23.27	2.29	1.14	2.29	0.76	1.53	0.76	0.38	2.29	0.38
tenocyte, donor3	11768-123I4	29.28	1.85	1.85	1.85	0.74	1.48	1.11	0.00	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	63.40	5.27	3.06	8.16	0.51	2.55	0.51	2.04	1.19	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	69.98	3.24	4.16	5.40	1.54	1.08	1.85	1.54	1.08	1.23
teratocarcinoma cell line:PA-1	10807-111A6	61.22	7.13	2.01	3.25	1.08	1.24	0.93	0.62	0.93	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	123.39	3.30	5.20	5.33	1.27	0.89	1.14	1.78	1.14	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	105.89	5.67	3.40	4.92	2.27	0.00	0.38	3.03	1.51	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	86.60	4.47	3.49	2.73	0.87	0.87	1.09	1.20	0.22	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	109.44	0.65	5.21	1.30	0.00	0.00	0.33	0.33	1.63	0.98
testis, adult, pool1	10026-101D8	275.63	17.07	17.61	2.58	1.93	4.83	0.54	1.07	16.32	2.79
testis, adult, pool2	10096-102C6	567.92	10.37	41.50	2.71	1.80	12.63	2.26	1.35	4.96	5.86
thalamus - adult, donor10196	10168-103B6	40.85	3.31	1.10	3.31	2.21	2.21	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	67.98	6.25	4.06	1.25	1.56	1.41	0.16	0.16	1.25	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	56.97	0.00	10.78	1.54	0.00	1.54	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	29.31	1.15	1.15	0.16	1.32	1.15	0.66	0.33	0.33	0.33
thalamus, newborn, donor10223	10366-105F6	16.11	0.00	0.58	5.18	2.30	5.18	2.30	3.45	0.00	0.00
throat, adult	10209-103G2	89.63	1.00	1.75	0.75	1.00	0.50	1.25	0.50	1.00	0.75
throat, fetal, donor1	10061-101H7	59.11	2.44	1.52	1.52	0.30	1.83	1.52	0.00	0.91	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	51.07	5.37	3.18	1.79	3.18	7.95	0.79	0.99	0.60	0.79
thymus, adult, pool1	10027-101D9	143.56	3.88	9.64	0.40	1.89	1.29	1.49	0.10	3.18	0.70
thymus, fetal, pool1	10043-101F7	115.54	4.26	6.03	1.04	1.35	1.25	1.14	0.31	1.45	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	95.86	1.33	4.39	1.99	1.20	0.80	0.66	0.93	1.06	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	91.22	5.59	1.96	0.70	0.98	0.70	0.98	0.56	1.26	0.42
thyroid, adult, pool1	10028-101E1	91.54	2.15	2.89	0.56	1.40	0.28	0.65	0.37	1.96	0.28
thyroid, fetal, donor1	10060-101H6	69.87	2.90	1.85	1.05	0.79	1.32	0.53	0.00	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	52.35	3.08	0.00	0.00	3.08	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	88.38	3.95	3.49	2.33	1.86	0.47	0.70	0.23	1.86	1.63
tongue, fetal, donor1	10059-101H5	84.73	2.36	1.58	1.18	2.76	0.39	0.79	0.39	0.79	1.18
tonsil, adult, pool1	10047-101G2	94.37	3.21	6.21	2.00	1.10	1.00	1.20	0.20	0.90	0.20
trachea, adult, pool1	10029-101E2	81.96	3.52	4.09	0.98	0.49	0.57	0.33	0.57	1.15	0.82
trachea, fetal, donor1	10058-101H4	56.55	1.15	2.31	0.38	3.46	1.54	0.77	0.00	0.77	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	35.07	0.71	1.77	1.06	0.35	1.06	1.42	0.71	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	41.03	2.63	1.93	2.13	3.14	1.72	2.53	2.13	0.51	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	97.30	4.39	3.76	6.42	3.13	3.29	0.78	1.72	1.57	0.63
tridermal teratoma cell line:HGRT	10694-109G1	20.93	1.90	0.00	3.81	1.90	5.71	3.81	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	57.14	3.22	1.86	2.88	1.61	1.52	0.76	0.51	0.68	0.17
umbilical cord, fetal, donor1	10057-101H3	64.68	2.09	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	63.13	5.29	3.24	1.19	1.71	0.68	1.02	0.17	0.17	0.51
uterus, fetal, donor1	10055-101H1	46.07	4.10	3.07	0.51	1.02	5.63	0.00	0.51	0.51	1.02
vagina, adult	10204-103F6	60.74	1.94	0.00	1.94	0.65	0.65	0.00	0.00	0.65	0.00
vein, adult	10191-103E2	71.24	2.41	3.29	2.63	2.19	0.66	1.32	0.00	1.10	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	49.67	2.94	2.94	4.27	1.87	0.80	1.34	0.80	0.27	0.00